by funder - Politiques Publiques

07/061, ministere de la santé français 1

11100A, Recherches de l'ERA41 Mob et ERA40 aapser rattachées à l'axe 1 1

11150679, Fondecyt 1

11R103, Digues et ouvrages fluviaux : érosion, affouillements et séismes : DOFEAS 1

13L06181, ANR 2007 - Projet TerDOUEST - PGCU 1

13M09101, C2D2 2009 - Projet COACHS 1

13U10301, C2D2 2010 : BADIFOPS - BFUP Armé Ductile Instrumenté par Fibres Optiques pour des Applications Parasismiques 3

13W12111, Projet ALGOROUTE - Convention Région Pays de la Loire/LCPC n 2011 10085 1

1443040, NSF DIBBs 1

1444573, NSF PGRP 1

14730, “France Recherche Nord et Sud Sida-HIV et Hépatites” 1

15/JTA, Sir Jules Thorn Award for Biomedical Science 1

19YF1419100, Shanghai Sailing Program 1

1F31NS106828‐01A1, National Institute of Neurological Disorders and Stroke 1

1U01‐HL‐117718‐01, National Heart, Lung, and Blood Institute 1

2003, Public Health Research Programme 1

2007 2

2007-3612/001-001 1

2012, Agence de Biomedecine 1

201306150010, China Scholarship Council 1

2013 French program for Hospital Clinical Research ; French Ministry of Social Affairs and Health 1

201406150039, China Scholarship Council 1

2014-51181-2237, USDA NIFA SCRI 1

2014, Société Francophone de Néphrologie et de Dialyse 1

201506040050, China Scholarship Council 3

21140822, Consejo Nacional de Innovación, Ciencia y Tecnología 1

2200727156, French Ministry of Labour, International 1

282910, Seventh Framework Programme 1

35, Ligue Contre le Cancer 1

50% UE 7

59000386 1

5NE11OH010461-03-00, National Institute for Occupational Safety and Health 1

5UL1‐TR000130‐05, National Center for Research Resources 1

61201349, National Natural Science Foundation of China 1

61673260, National Natural Science Foundation of China 1

61701297, National Natural Science Foundation of China 2

61703114, 61673126 and U1701261, National Natural Science Foundation of China 1

6th Framework Programme EC 1

8302, Genome Canada 1

Abbott 1

AbbottAbbott 1

Abbvie 2

Abbvie, MSD, Biocodex, Ferring, Covidien, Takeda 1

Academy of Finland [206038, 121647] 1

Accessible en ligne : <br />http://www.sante.gouv.fr/drees/dossier-solsa/ 1

ACI 1

ACI "Jeunes chercheurs" financée par le Ministère délégué à la recherche et aux nouvelles technologies. 1

Acknowledgements. This work benefited from the support of the project POLLUS-COPE ANR-15-CE22-0018 of the French National Research Agency (ANR). It has been also supported by the MASTER project that has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie-Slodowska Curie grant agreement N. 777695. 1

Actelion 1

Action concertée incitative (ACI) « Sécurité routière et Société » financée par ministère délégué à la Recherche, l’Institut national de recherche sur les transports et leur sécurité (INRETS) et le Centre national de la recherche scientifique (CNRS). 1

ADAPAEF 44 2

ADEME 7

ADEME 126000039 1

ADEME (Agence pour le développement et la maîtrise de l'énergie) Programme SBSS Sciences biomédicales-santé-société (INSERM-CNRS) ATC Environnement santé du Ministère de la recherche Programme "Analyse des discours de santé publique" MSH Bretagne 1

Ademe (Contrat Inra-Ademe n° 14-60-C0064) 1

ADEME (N TEZ17-42) 1

ADEME, Programme Déchets et Société 1

ADEME, PUCA, LabEx AE&CC 1

ADEME, UGA, CNRS, GEM, CEA 1

Adisseo 1

ADR Région Rhône-Alpes 2005 1

AD thanks the “Institut National du Cancer” for its financial support for this project.This study was funded by a grant from the Institut National du Cancer(INCa). 1

Advanced Bionics AG (Stafa, Switzerland) ; Cochlear France (Saint-Aubin, France) ; Vibrant Medel Hearing technology (Sofia Antipolis, France) ; Oticon medical/Neurelec (Vallauris, France) 1

AELB, FEDER 1

AESN 1

AFB 2

AF Centre of Excellence and FiDiPro programs [251314, 263246] 1

AFD 1

AFRETH (French Association for Hydrothermal Research) Auvergne Regional Council, Clermont-Communaute, League against Cancer (Puy de Dome committee CD63) 1

Agefiph 3

Agence de la Biomédecine/Agence Régionale de Santé de la Guadeloupe/Inserm-REACTing. 1

Agence de la Biomédecine, Fondation pour la Recherche Médicale and "Association pour l'Utilisation du Rein Artificiel" (AURA). H.D. is the recipient of a "Contrat d'Interface" from Assistance Publique-Hôpitaux de Paris. 1

Agence de l'environnement et de la maîtrise de l'énergie (ADEME) 1

Agence de l'Environnement et de la Maîtrise de l'Énergie (ADEME) 1

Agence de l’Environnement et de la Maîtrise de l’Energie (ADEME), Ministère de l'Agriculture, de l’Agroalimentaire et de la Forêt (MAAF), Ministère de l’Ecologie, du Développement Durable et de l'Energie (MEDDE) 1

Agence de l’Environnement et de la Maîtrise de l’Energie (ADEME), Ministère de l'Agriculture, de l’Agroalimentaire et de la Forêt (MAAF), Ministère de l’Ecologie, du Développement Durable et de l'Energie (MEDDE) 2

'Agence française de l'environnement et de la maîtrise de l'énergie (Ademe, convention n° 07 10 C 0019), projet climencored 1

Agence Française pour la Biodiversité (projet SYSTEMYC) 1

Agence National de la Recherche [ANR Blan06-2\₁39420] 1

Agence Nationale de la Recherche 4

Agence Nationale de la Recherche: 05-BDIV-014 ABIME; Ministere de l'Ecologie, de l'Energie, du Developpement Durable et de la Mer: 0001077-Diva2 BIO2M; Languedoc-Roussillon regional government 1

Agence Nationale de la Recherche - ANR PATERMED Paysages et Terroirs Méditerranéens 1

Agence Nationale de la Recherche Française (ANR-09-TECS-002) Agglomération de Laval Conseil Général de la Mayenne 1

Agence Nationale de la Recherche, France (ANR). 1

Agence Nationale de la Recherche. Grant Numbers: ANR‐10‐LABX‐25‐01, ANR‐10‐LABX‐41, ANR‐11‐IDEX‐0002‐02, LABEX DRIIHM ANR-11-LABX-0010 1

Agence Nationale de la Recherche [no. ANR-05-PNRA-010]; Direction Générale de la Santé (Ministry of Health); Ecole Doctorale Galilée, University of Paris 13, Sorbonne Paris Cité [doctoral fellowship] and United States National Institute for Diabetes, Digestive and Kidney Diseases [grant number R44DK103377] 1

Agence Nationale de la Recherche, programme Systerra référence ANR -08-STRA-13 1

Agence Nationale de la Recherche, ANR Agence Nationale de la Recherche, ANR Association Sorbonne UniversitÃ© Institut National de la SantÃ© et de la Recherche MÃ©dicale, Inserm 1

Agence Nationale de la Recherche, ANR Horizon 2020 Framework Programme, H2020: 654109 Agence Nationale de la Recherche, ANR 1

Agence Nationale de la Recherche, ANR Horizon 2020 Framework Programme, H2020: 777695 1

Agence Nationale de Recherches sur le Sida et les Hepatites Virales 1

Agence Nationale de Recherches sur le Sida et les Hépatites Virales 1

Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS); Inserm; Collège des Universitaires de Maladies Infectieuses et Tropicales (CMIT ex APPIT); Sidaction Ensemble contre le Sida; associated pharmaceutical companies: Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Gilead Sciences, Pfizer and Roche. 1

Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM 2014-S035) 1

Agència de Gestió d’Ajuts Universitaris i de Recerca, Grant number: 2015 DI 049. 1

Agencia de InnovaciÃ³n y Desarrollo de AndalucÃa, IDEA 15110027 1

AGEPEAU 1

Agglomération Grand Dole 1

A grant from l’Association pour le Développement de la Réanimation (ADR, Nantes). 1

A grant from the Fondation pour la Recherche Médicale. 1

A grant from the French Ministry of Health (PHRC-13-0224, 2013). 1

A grant from The Israeli Ministry of Science, Technology and Space No. 62466 and the 7th Framework Program FP7‐Health‐2013‐INNOVATION‐1‐603049 of the European Commission. 1

Agrimonde Terra 1

Agrivair, AGREV 3 1

Aguettant 1

Alimentation et nutrition humaine (PNRA) : ANR ALIMINFO 1

Allocation de recherche de la Région Provence-alpes- Côte d'Azur (PACA) 1

Allocation du Ministère français de l'Enseignement Supérieur et de la Recherche 1

Allocation post-doctorale R2DS 1

Allocation régionale 2011-2014, Dispositif ARC 8/Rhône-Alpes 1

ALLOCIRCO 1

AMMA 1

AMMA, French ECCO-PNRH program, ORE programme of the French Research Ministry, IRD 1

Amplyx 1

André Tchernof is the recipient of a Fonds de la recherche en santé du Québec Senior investigator scholarship. 1

ANR 6

ANR-011-ALID-002-02 OCAD, INRAMetaprogram, 1

ANR-08-gouv-0040 MUTORG-ADMI 1

ANR-10-BTBR-04, Agence Nationale de la Recherche 1

ANR-10-CEPL-011,ORACLE 1

ANR-10-LABEX-0001-01 ; Projet Scenarice (no. 1201-008, Agropolis Fondation - Cariplo Fondation) 1

ANR10 LABX56, ARC - Environnement Région Rhone-Alpes, Grenoble-Chambéry DIPEE CNRS, ANR11 INBS-0001AnaEE Services 1

ANR-11-ALID-0006ILLIAD 2

ANR-11-IDEX-0007, Investissements d'Avenir 1

ANR-11-INBS-0001 1

ANR-11-LABX-0004, Agence Nationale de la Recherche 1

ANR-11-LABX-0018-01, Agence Nationale de la Recherche (FR) 1

ANR-11-LABX-0048, LABEX ECOFECT 1

ANR-13-ALID-0001 ; Ministere de la Sante ; Sante Publique France ; Institut National de la Sante et de la Recherche Medicale (INSERM) ; Institut National de la Recherche Agronomique (INRA) ; Conservatoire National des Arts et Metiers (CNAM) ; Paris 13 University 1

ANR-13-ALID-0004 Sustain'apple 1

ANR-13-BSV7-0006, Agence Nationale de la Recherche 1

ANR-13-BSV7- 0011, FUNFIT project 1

ANR-13-CESA-0009 1

ANR-13-JSH1-0008, Agence Nationale de la Recherche 1

ANR ACASSYA 1

ANR Agence Nationale de la Recherche : ANR-05-PADD-003 "Programme Agriculture et Développement Durable" 1

ANR (Agence Nationale de la Recherche, France) 2

ANR [ANR-05-PNRA-010]; DGS (Ministry of Health); Mederic; Sodexo; Ipsen; MGEN; Pierre Fabre 2

ANR (ANR-08-BIOE-0006) 1

ANR [ANR-15-FRAL-0002] ; DFG [DFG HU 411/18-1] 1

ANR Apisgene Bovano 1

ANR Biodiversité (ANR-06-BDIV-008-01 ) ; Agropolis Fondation (RTRA, Montpellier, BIOFIS) (1001-001) 1

ANR CECILE 1

ANR, CNRS Interdisciplinaire MIE, Trop.Med 1

ANR COBINA 1

ANR DAUME (ANR‐2010‐STRA‐007‐01) 1

ANR DAUME Durabilité des Agricultures Urbaines en Méditerranée 1

ANR DAUME Durabilité des agricultures urbaines en Méditerranée (ANR-2010-STRA-007-01) 1

ANR DAUME Durabilité des Agricultures Urbaines en Méditerranée (ANR-2010-STRA-007-01) 1

ANR (Etat)Région Bretagne 1

ANR INDEX 2

ANR Interra (programme Systerra, ANR-09-STRA-04) 1

ANR JASMINN Protection du foncier agricole périurbain en Méditerranée : enjeux de justice et innovations foncières 1

ANR Legitime 1

ANR MULTIMEX 1

ANR OCAD 1

ANR OPALINE 1

ANR ORACLE, PIREN-Seine 1

ANR Prigoue 2

ANR PRODDIG 1

ANR project 1

ANRS 1

ANRS (France Recherche Nord and Sud Sida-HIV Hépatites) ; National Institute of Cancer (INCa, Institut National du Cancer) ; ARC foundation ; ANRS ; French Ministry of Health ; Santé publique France Institute ; Institut National de la Santé et de la Recherche Médicale ; Institut National de la Recherche Agronomique ; Conservatoire National des Arts et Métiers ; Fondation pour la Recherche Médicale ; Paris 13 University 1

ANRS (France REcherche Nord & sud Sida-HIV Hepatites-FRENCH) 1

ANRS (France Recherche Nord & sud Sida‐HIV Hépatites‐FRENCH)HECAM (Hepatocellular Carcinoma Multi‐Technological) Consortium 1

ANRS (France Recherche Nord&sud Sida-vih Hepatites), ANR (Agence Nationale de la Recherche), DGS (Direction Générale de la Santé) and MSD, Janssen, Gilead, Abbvie, BMS, Roche.The biobank of the cohort is stored by Cell&Co Biorepository, Pont du Château, France and has been managed temporarily by Centre de Ressources Biologiques-HUEP, Hôpital St Antoine, Paris, France. 1

ANRS-PEDIACAM study group 1

ANRS, Sidaction 1

ANRS, SIDACTION 1

ANRT; NATURALIA-ENVIRONNEMENT 2

ANRT (Thèse CIFRE) 1

ANRU, Métropole Européenne de Lille 1

ANR Villes durables 2010 1

ANR VisiojusticeGip mission de recherche Droit et justice 1

Anses 1

ANTADIR AO2006; UCB-Pharma Ltd AO2007 ; CARDIF AO2007. 1

AOM 03018 1

API/N/041, French Ministry of Health (Programme Hospitalier de Recherche Clinique Interrégionale) 1

(appel d'offres international) 1

(appel d'offres national ou régional) 2

Arab Gulf University 1

ARC 5 1

ARC Energie Région Rhône-Alpes 2

ARC Nautilus 1

ArcticNet Network of Centres of Excellence of Canada 1

Arsanis 1

ASM is supported by a "European Young Investigator Award" from the European Science Foundation and the National Institute on Aging, NIH (R01AG013196; R01AG034454). MK is supported by the BUPA Foundation, the National Institutes of Health (R01HL036310; R01AG034454) and the Academy of Finland. The Whitehall II study is also supported by a grantfrom the British Medical Research Council (G0902037) and the British Heart Foundation. 1

AS-M is supported by the European Science Foundation and the French Ministry of Research. MM is supported by an MRC Research Professorship, MK by the Academy of Finland (grants 117604, 124322 and 124271) and MS by the British Heart Foundation. The Whitehall II study is supported by the Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute (HL36310), National Institute on Aging; Agency for Health Care Policy Research (HS06516); and the John D and Catherine T MacArthur Foundation 1

A.S-M is supported by the National Institute on Aging, National Institutes of Health (NIH;R01AG013196; R01AG034454). M.K is supported by the Medical Research Council (K013351), the Economic and Social Research Council, the NIH (R01HL036310; R01AG034454), and the Academy of Finland. A.E has received funding from the FrenchAgence Nationale de la Recherche (2009–2012). E.J.B is supported by the British Heart Foundation(RG/13/2/30098). 1

ASM received funding for the study from the Horizon 2020 Framework Programme (643576) and the National Institute on Aging (R56AG056477, R01AG034454). MK received funding from the Medical Research Council (K013351, R024227), Horizon 2020 Framework Programme (633666), the Academy of Finland (331492) and NordForsk. 1

A. S.-M. was supported by a "Chaire d'excellence, 2004" award from the French Ministry of Research. The Whitehall II study has been supported by grants from the Medical Research Council; the British Heart Foundation; the Health and Safety Executive; the Department of Health; the US National Heart, Lung, and Blood Institute (grant HL36310); the US National Institute on Aging; the Agency for Health Care Policy and Research (grant HS06516); and the John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health. M. M. was supported by a Medical Research Council research professorship. 1

AS received funding from the Wellcome Trust (200163/Z/15/Z https://wellcome.ac.uk/). The Whitehall II study is supported by grants from the US National Institutes of Health (R01AG056477 https://www.nih.gov/), the UK Medical Research Council (MRC K013351, MR/R024227 https://mrc.ukri.org/), and British Heart Foundation (RG/13/2/30098). AS, GLe and GLi are supported by the University College London Hospitals’ National Institute for Health Research Biomedical Research Centre (https://www.uclh.nhs.uk/Research/BRC/Pages/Home.aspx), GLi was supported in part by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart’s Health NHS Trust (https://clahrcnorththames.nihr.ac.uk/). 1

Assistance Publique des Hopitaux de Marseille (AORC) 2012-54 1

Assistance Publique des Hopitaux de Paris (APHP-CRC, FESFM) [01020, P010605] 1

Association ANTARES 1

Association de Coordination Technique pour l'Industrie Agro-Alimentaire, 16 rue Claude Bernard, Paris, Cedex 05 1

Association des Biologistes de l'Ouest 1

Association du Pays de Chaumont 1

Association Fer et Foie, Rennes, France 1

Association for Research and Teaching in Ophthalmology (ARFO, Grenoble, France). 1

Association France-Alzheimer and French Ministère de l’Enseignement Supérieur et de la Recherche. 1

Association France Alzheimer, Merck, Sharp and Dohme-Chibret Laboratories (WestPoint, PA), EISAI laboratory (france) 1

Association Francois Aupetit; MSD France; Helmsley Charitable Trust 1

"Association Lyonnaise de Logistique Post-Hospitaliere" (ALLP), Hospices Civils de Lyon 1

Association Ouest Atlantique Anjouan 1

Association Pluriagri 1

Association pour la Recherche sur le Cancer (ARC) 1

Association SPACE AERO 1

Astella 1

Astellas 2

Astellas. 1

AstraZeneca 1

Astrazeneca; eli lilly; Roche 1

ASTRAZENECA SA HELLAS; ELAIS UNILIVER SA; ELPEN Pharmaceutical Company, Inc; GENZYME HELLAS LLC; SANOFI-AVENTIS; SCHERING-PLOUGH A.F.V.E.E.; SOLVAY Pharma M.E.P.E. 1

Ateliers de création urbaine de la Région Île-de-France 1

Augustinus Foundation; Avera Institute for Human Genetics (AIHG); AXA Research Fund; Belfast City Hospital Trust Fund; Biobanking and Biomolecular Resources Research Infrastructure (BBMRI -NL) [184.021.007]; Biotechnology and Biological Sciences Research Council (BBSRC); Bristol-Myers Squibb; Center for Inherited Disease Research (CIDR); Centre for Medical Systems Biology (CMSB); CERA Foundation; Commissariat a L'Energie Atomique (CEA)-Centre National de Genotypage (CNG); Danish Agency for Science, Technology and Innovation (DASTI)/The Danish Council for Independent Research (DCIR) [11-107308]; Danish National Research Foundation (DNRF); Department of Health and Social Services (Northern Ireland); DFG-Cluster of Excellence 'Inflammation at Interfaces'; Dunhill Medical Trust [R124/0509]; Egmont Foundation; Estonian Science Foundation [7859]; Estonian Government [SF0180142s08]; European Research Council (ERC) [230374]; European Science Foundation (ESF) [EU/QLRT-2001-01254]; European Union [FP5-QLK6-CY-2001-00128, FP6-LIFESCIHEALTH-36894, FP6-LSH M-CT-2004-503270, FP7-HEALTH-2007-B-223004, FP7-HEALTH-F4-2007-201413, FP7-HEALTH-F4-2008-202047, FP7-HEALTH-2009-single-stage-242244, FP7-HEALTH-2010-two-stage-259679]; Fondation Caisse d'Epargne Rhone-Alpes Lyon CERAL; Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health (NIMH) [MH081802]; GenomEUtwin [EU/QLRT-2001-01254, QLG2-CT-2002-01254]; Guy's & St Thomas' NHS Foundation Trust; Health Foundation; Heart and Lung foundation [20070481]; Innovation-Oriented Research Program on Genomics (SenterNovem) [IGE05007]; Institute for Ageing and Health; Institut National de la Recherche Agronomique (INRA); Institut National de la Sante et de la Recherche Medicale (INSERM); King's College London; Medical Research Council (MRC) [G0500997, G0601333]; Ministere de l'Enseignement superieur et de la Recherche (MESR); National Institutes of Health (NIH)/National Institute of Aging (NIA) [P01AG08761, R01D0042157-01A, U01DK066134]; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre; NBIC BioAssist [NWO-NBIC/BioAssist/RK/2008.024]; Netherlands Consortium for Healthy Ageing (NCHA) [050-060-810]; Netherlands Genomics Initiative (NGI); Netherlands Heart Foundation (NHF) [2001 D 032]; Netherlands Organization for Scientific Research (NWO, MagW/ZonMW) [904-61-090, 904-61-193, 480-04-004, 400-05-717, Spinozapremie 56-464-14192, 175.010.2005.011, 911-03-012, 985-10-002, Addiction-31160008, Middelg-root-911-09-032]; Netspar - Living longer for a good health; NHS North of Tyne (Newcastle Primary Care Trust); Pharmacy Foundation; Regione Autonoma della Sardegna; Rutgers University Cell and DNA Repository [NIMH U24 MH068457-06]; Swedish Research Council [M-2005-1112]; Tampere University Hospital and Academy of Finland; Danish Interdisciplinary Research Council; Health Foundation (Helsefonden); Ministry for Higher Education; National Program for Research Infrastructure [09-063256]; March of Dimes Birth Defects Foundation; Swedish Foundation for Strategic Research (SSF); Unilever Discover Colworth; Universite Paris 13; University of Calabria; University of Tartu [SP1GVAR-ENG]; Velux Foundation; VU University's Institute for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam (NCA); Wellcome Trust [084762, 085475, 087436]; IDEAL [FP7-HEALTH-2010-two-stage-259679]; Research and Education into Ageing-0153; European Regional Development Fund 1

Australian Research CouncilKONE foundation 1

Australian Rotary Health Grant [RM 31643] 1

Austria, Federal Ministry of Science, Research and Economy (BMWFW); France, Ecole Supérieure d’Agricultires (ESA); Germany, Federal Ministry of Food and Agriculture (BMEL) represented by Federal Office forAgriculture and Food (BLE); Ireland, Department of Agriculture, Food and the Marine (DAFM) and the Health Research Board (HRB); Spain, Instituto de Salud Carlos III, and the SENATOR trial (FP7-HEALTH-2012-305930); The Netherlands, The Netherlands Organisation for Health Research and Development (ZonMw). 1

Autorité des normes comptables 1

Autres 4

Autres (partenariat avec la sphère publique (sans AO)) 4

AVieSan national program (French Alliance nationale pour les sciences de la Vie et de la Sante) ; French "Agence Nationale de la Recherche" : ANR-10-BINF-01 1

Avis révisé de l’Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail relatif à l’exposition aux pesticides des personnes travaillant dans l’agriculture 7

AWARE 1

Basilea 1

, Baxalta Innovations GmbH, a Takeda company, Vienna, Austria 1

, Baxalta US Inc., a Takeda company, Westlake Village, CA, USA 1

Baxter Healthcare CorporationBaxter Healthcare Corporation 1

Bayer 1

BBSRC [BB/M017702/1]; ANR [ANR-15-CE1-0008] 1

Belgian American Education Foundation 1

Benjamin Delessert Institut, Nutricia ; Assistance Publique des Hopitaux de Paris 1

BIA2003-01499 financé par le Ministerio de Ciencia et Tecnologia (Espagne) et la FEDER (Fondo Europeo de Desarrollo Regional) 1

BIA 2003 01499, Miniserio de Cencia y Tecnologia, Espagne 1

Bio-Rad laboratories 1

BIORARE project (ANR-10-BTBR-02) 1

Biosensors 1

Biotechnology and Biological Sciences Research Council Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I000348/1]; Wellcome Trust Wellcome Trust [BB/I000348/1]; Department for Environment, Food and Rural Affairs Department for Environment, Food & Rural Affairs (DEFRA) [BB/I000348/1, WC1101]; Scottish Government [BB/I000348/1, WC1101]; Natural Environment Research Council NERC Natural Environment Research Council [NE/R016429/1] 1

Boston Scientific 1

Bourgogne Regional Council; Spanish Education Ministry (M.E.C.) 1

Bourse de recherche ADEME (2004-2007) co-financée par EDF R&D 1

Bourse de thèse : La Région Guadeloupe ; Fonds Social Européen 2007/2013 ; Inra, Département Environnement et Agronomie 1

Bourse de thèse : La Région Guadeloupe ; Fonds social européen (FSE) 2007/2013 ; Inra, Département Environnement et Agronomie 1

Bourse doctorale CNAF (2006-2009)Programme de recherche "Genre et politiques sociales" (DREES - MiRE) 2007-2009Poste ATER 2011-2012 IUT Carrières Sociales de Tours 1

Bourse doctorale de l'Ecole des Ponts - ParisTech 1

Bourse ministérielle 1

Bourse MNHN 1

Bpifrance 1

Bpifrance; Conseil Regional des Pays-de-la-Loire 1

Brazilian National Council for Scientific and Technological Development (CNPq) and Brazilian Ministry of Health Department of Science and Technology (DECIT). 1

BRE060, Saskatchewan Pulse Growers 1

BRGM 1

BRGM-DEV/ONEMA 1

British Heart Foundation 1

B.R.K. has received funding from the Lundbeck Foundation. S.K. has received funding from the Norwegian Ministry of Health and Care Services. H.M.O. has received funding from the Finnish Cultural Foundation, Jalmari and Rauha Ahokas Foundation, Sigrid Juselius Foundation, Emil Aaltonen Foundation, Päivikki and Sakari Sohlberg Foundation, Orion Farmos Research Foundation and Instrumentarium Science Foundation. 1

BT was supported by the Fondation pour la Recherche Médicale (FRM), the Agence Nationale pour la Recherche sur le Sida et les Hépatites (ANRS) and the Société Nationale Française de Médecine Interne (SNFMI). 1

Burgundy Regional Conseil + Bureau Interprofessionnel des Vins de Bourgogne (France) and Conselho Nacional de Desenvolvimento Cientifico e Técnologico (CNPq), programa “Ciência sem Fronteiras” (Brazil) 1

Caisse nationale d’assurance maladie (CNAM) 1

Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, Haute Autorité de la Santé, Institut National de Prévention et d’Education pour la Santé, Conseils Régionaux de Bourgogne, Fondation de France, Ministry of Research-Institut National de la Santé et de la Recherche Médicale Program, Cohortes et collections de don-nées biologiques, Mutuelle Générale de l’Education Nationale, Institut de la Longévité, Conseil Général de la Côte d’or, National Institute on Aging (R01AG034454 to S.S.; R01AG013196 to J.H.), French National Research Agency (C.T.), Fondation Plan Alzheimer (C.T.). 1

Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Agence Française de Sécurité Sanitaire des Produits de Santé, régions Aquitaine, Bourgogne et Languedoc-Roussillon, Fondation de France, programme du Ministère de la Recherche et Inserm 'Cohortes et collection de données biologiques' et Novartis 1

Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Agence Française de Sécurité Sanitaire des Produits de Santé, Régions Aquitaine, Bourgogne et Languedoc-Roussillon, Fondation de France, programme Ministère de la recherche-Insermof Research-Inserm Cohortes et collection de données biologiques 1

Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Agence Française de Sécurité Sanitaire des Produits de Santé, the Regional Governments of Aquitaine, Bourgogne and Languedoc-Roussillon and, the Fondation de France, the Ministry of Research-Inserm Programme "Cohorts and collection of biological material" 1

Caisse Primaire d'Assurance Maladie de Paris; Institut Benjamin Delessert 1

Cambridgeshire, Ely, ADDITION, EPIC-Norfolk, and the Norfolk Diabetes studies were funded by the MRC with support from NHS Research & Development and the Wellcome Trust. RP received grants from Koeln Fortune and Marga- und Walter-Boll Stiftung. IB acknowledges funding from Wellcome Trust grant 077016/Z/05/Z and United Kingdom NIHR Cambridge Biomedical Research Centre and the MRC Centre for Obesity and Related Metabolic Diseases. PW is supported by BHF fellowship grant FS/10/005/28147. NT-pro-BNP determination in FINRISK97 was done as a part of the MORGAM Biomarker Study funded in part by the Medical Research Council London (G0601463, identification no. 80983) and Roche Diagnostics provided test reagents. VS was supported by the Academy of Finland, grant no 129494. 1

Campus France - Projet Hubert Curien Sakura (France - Japon) 1

Cancéropôle Ile-de-France, Ile-de-France Region (PhD grant) 1

Canceropole Ile-de-France; Paris region 2

Cancéropôle Ile de France/Région Ile de France ; QUANTICA emergence project 1

Cancer Research UK [C570/A11691, C8221/A19170]; National Institute on Aging Intramural Research Program, Prostate Spore Grant [CA58236]; US Department of Health and Human Services; National Institutes of Health [U01 CA63673, P01 CA 33619, R37 CA 54281, RO1 CA49764, CA37429, CA42182, CA58684, CA57374, CA94028, CA55075]; Clinical Nutrition Research Unit [P30 DK35816]; Department of Defense [DAMD1-94-J-4265]; Europe Against Cancer Programme of the European Commission; German Cancer Aid; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund of the Spanish Ministry of Health; Centros de Investigacion Biomedica en Red Epidemiologia y Salud Publica, Barcelona, Spain; Medical Research Council, UK; Stroke Association (UK); British Heart Foundation; Department of Health (UK); Food Standards Agency (UK); Greek Ministry of Education; Greek Ministry of Health and Social Solidarity; Hellenic Health Foundation; Italian Association for Research on Cancer; Italian National Research Council; Dutch Ministry of Public Health, Welfare and Sports; Dutch Ministry of Health; Dutch Prevention Funds; LK Research Funds; Dutch Zorg Onderzoek Nederland; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane, Sweden; German Federal Ministry of Education and Research [FK 0313846A]; Deutsche Krebshilfe [10-1793 Scholl]; Cancer Society of Finland; National Heart, Lung, and Blood Institute [HL35464]; US National Cancer Institute; Dutch Cancer Society [UM 2009-4556]; Intramural Research Program; French Ministry of Health/Direction Generale de la Sante 1

Cancer Research UK [C8221/A19170] 1

CAPES (Programa Ciencias sem Fronteiras, Pesquisador Visitante Especial) 88881.068106/2014-01 1

Cardiovasculaire, Obesite, Rein, Diabete (CORDDIM) Program 1

CASDAR 1

Casdar et Ademe 1

Cde Ugitech 4500109299 - réf. Arm 80841 1

CEA 1

Celtipharm 1

Centre Hospitalier Régional et Universitaire (CHU) de Lille, employée sur des fonctions: 1- de recherche en géographie et géomatique en santé et sur des fonctions d'infirmière - expertise médicale dossier PMSI - pendant la thèse 1

CENTRE LEON BERARD 1

Centre National de la Recherche Scientifique 1

Centre National de la Recherche Scientifique (CNRS) 2

Centre National de la Recherche Scientifique, the Institut National de la Sante' et de la Recherche Me' dicale, the Universite' Pierre et Marie Curie, and by grants from the Fondation de France, the Fondation pour la Recherche Me' dicale, the French Ministry of Research (Agence Nationale pour la Recherche), and the European Union. L.M.'s team is an ''Equipe Fondation pour la Recherche Medicale''. S. Diaz is supported by a fellowship from IBRO and Region Ile de France DIM STEM 1

Centre National du Livre 1

CEP-2009 program; project ‘Coastal Environmental Changes: Impact of sea LEvel rise' (CECILE) ANR-09-CEP-001-01 1

Ce rapport a reçu le soutien financier de l’IRES (Institut de recherches économiques et sociales)et a été réalisé dans le cadre de l’Agence d’objectifs. 1

CERVIFER 3

Ce séminaire a été financé par le plan urbanisme, construction et architecture (PUCA) du ministère de l'écologie et du développement durable 1

Cet article est issu d'une recherche financée dans le cadre du programme de recherche de la Mire (Mission Recherche de la DREES) en santé mentale (appel d'offres 2002 en partenariat avec l'Inserm et le CNRS) 1

Cet Atelier et la présente publication ont bénéficié du soutien financier de la Maison des sciences de l’homme et de la société de Toulouse (MSHS-T) et du Programme pour et sur le développement régionl (PSDR3) en Midi- Pyrénées, cofinancé par la Région Midi-Pyrénées, l’Institut national de la recherche agronomique (INRA), le Fonds européen de développement régional (FEDER) et le Groupement d’intérêt scientifique (GIS) TOULOUSE AGRICAMPUS. 1

Ce travail a bénéficié d'une aide de la région Bretagne dans le cadre du dispositif « Stratégie d’Attractivité Durable » (projet F3) et d’une aide de l'Etat gérée par l'Agence Nationale de la Recherche au titre du programme « Investissements d'avenir » portant la référence ANR-10-LABX-19-01. 1

Ce travail a bénéficié d’une aide de la région Bretagne dans le cadre du dispositif « Stratégie d’Attractivité Durable » (projet F3) et d’une aide de l’Etat gérée par l’Agence Nationale de la Recherche au titre du programme « Investissements d’avenir » portant la référence ANR-10-LABX-19-01. 1

Ce travail a bénéficié d'une aide de l'Etat gérée par l'Agence Nationale de la Recherche au titre du programme " Investissements d'avenir " portant la référence ANR-10-LABX-93-01. This work was supported by the French National Research Agency, through the program Investissements d'Avenir, ANR-10--LABX-93-01. 7

Ce travail a bénéficié d'une aide de l'Etat gérée par l'Agence Nationale de la Recherche au titre du programme « Investissements d'avenir » portant la référence ANR-10-LABX-93-01.This work was supported by the French National Research Agency, through the program Investissements d'Avenir, ANR-10-LABX-93-01. 1

Ce travail a bénéficié d’un financement de la part du MEEDDAT – PUCAMinistère de la recherche – CNRS 1

Ce travail a été conduit dans le cadre du projet de recherches Mouve financé par L'agence Nationale de la Recherche 1

Ce travail a été conduit dans le cadre du projet de recherches Mouve financé par L'agence Nationale de la Recherche. 1

Ce travail a été réalisé avec l'appui financier du "Conseil Français de l'Energie, du Ministère de l'Ecologie, du Développement Durable et de la Mer (MEDDM - Programme PDD 'Paysage et Développement Durable"), de l'Agence française de l'Environnement et l'Energie (ADEME, Convention n° 07 10 C 0019), de la Région Ile-de-France (R2DS) et du Programme Interdisciplinaire Energie du CNRS. 1

Cette étude a reçu un financement de l'Institut national du cancer (Inca) dans le cadre du programme de soutien aux innovations diagnostiques et thérapeutiques coûteuses. 1

Cette étude est soutenue financièrement par la communauté européenne, la ligue nationale contre le cancer et ses comités départementaux, la Société 3M, la mutuelle générale de l'éducation nationale, l'institut Gustave-Roussy et le conseil général d'un certain nombre de départements 1

CFQCU 1

CGDD, Céreq 1

CGDD, Direction de la recherche et de l'innovation (DRI) 2

CH/09/002, Intermediate Clinical Research Fellowship 1

Chaire Recherche En Sûreté Organisation Hommes (RESOH) de l'IMT Atlantique 1

Chaire Territoires et Mutations de l’Action Publique de Science Po Rennes 1

Chair SDSC (Sustainable Demand Supply Chain), AgroParisTech 1

Charente Maritime Department; CPER (Contrat Projet Etat Region) of Charente Maritime; French national program EC2CO (CAPABIOC); CNRS organism 1

Chief Scientist Office of the Scottish Health Department; British Heart Foundation; Australian National Health and Medical Research Council [571281]; NIH [HL60712] 1

CHU de Dijon; Faculté de Médecine de Dijon; Association de cardiologie de Dijon; Union Régionale des Caisses d'Assurance Maladie de Bourgogne (URCAM); Agence Regionale de Sante (ARS) de Bourgogne; Conseil Regional de Bourgogne; Federation Francaise de Cardiologie (FFC) 1

CHU de Lille, Université de Lille 1

Cidara Therapeutics 1

CIERA - Centre interdisciplinaire d'études et de recherches sur l'Allemagne 1

CIFRE 4

CIFRE 2013/1066 Inter Beaujolais 1

CIFRE convention (2013/1066) ; Inter Beaujolais. 1

CIFRE Das 1

CIFRE PhD grant N° 584/2010 (TOTAL/UPMC) and by the CNRS/INSU "Actions Marges" Program 1

CIFRE PhD grant N° 584/2010 (TOTAL/UPMC). This paper is a contribution to the Projects AMEDITER ("Actions Marges" CNRS/INSU Programme), "Bassins néogènes et manteau en Méditerranée" (TerMEx CNRS/INSU Programme). 1

CIFRE Technopolis France 1

CIFRE Véolia Environement Recherche et Innovation 1

CILB, French Ministry of Ecology, ADEME (ITTECOP program), FRB 1

CIRADCAPESConseil Régional Ile de FranceBICAS 1

CIRAD / Montpellier SupAgro (IRC) 1

ClimaCop (IFRIS) 1

Climagie, Métaprogramme ACCAF 1

Clinical Research Board of Nice University Hospital; French Research Ministry; Department of Hormonology and Metabolic Disorders, Hopital Cochin, APHP, Paris-Descartes University, France 1

Cluster Innovatherm; Auvergne region 1

CNAF 1

Cnesco, Paris 1

CNES THEIA CES Artificialisation-Urbanisation 1

CNRS 5

CNRS Financement PEPPS PROSPER (2016) 1

CNRS Financement PEPPS SOCIOMODEL (2015) 1

CNRS (INEE / INSU) 1

CNRS INSIS Défi Energie projet Sociomod (2015) ; CNRS programme CAUSE - projet PROSPER 1

CNRS (PIDUD) et Ademe 1

CNRS project call NEEDS (nuclear, energy, environment, waste and society) 1

CNRS projects (RCP 826, Programme ECLIPSE) Projects AMEDITER (“Actions Marges” CNRS/INSU Programme) “Bassins néogènes et manteau en Méditerranée” (TerMEx CNRS/INSU Programme) 1

CNRT "Nickel et son environnement" 1

CNSA 1

Cofinancement CEA et DGA 1

COLCICCA 1

Colgate-Palmolive Europe 1

Collectivités territoriales 6

Collectivités territoriales (appel d'offres national ou régional) 2

Collectivités territoriales Autres (appel d'offres national ou régional) 1

Collectivités territoriales National hors Recherche (partenariat avec la sphère publique (sans AO)) 1

Collectivités territoriales (partenariat avec la sphère publique (sans AO)) 4

Comité de la Recherche Clinique et Translationnelle 1

Commande du P.R.E.S. Clermont-Université 1

Commissariat général à l’investissement (CGI) 1

Commission européenne 1

Commission Européenne, PCRD 7 1

Commission of the European Communities, specific RTD programme [QLK1-CT-1999-00 830] 1

Commission Permanente de Cooperation Franco-Quebecoise 1

Communication produite dans le cadre d'un travail de thèse financé par le cluster n°8 "Transports, territoires et société" de la Région Rhône-Alpes. 1

COMPROMISE project, COMPROMISE_MP-P1017716-CONV-0003 1

CONACYT (projects 280605, 293793, PDCPN-2017/5036) 1

Conseil Départemental de Seine-et-Marne 3

Conseil Regional Acquitaine, Mutuelle Generale de l'Education Nationale, Novartis, Institut de la Longevite, Fondation Plan Alzheimer, Caisse Nationale d'Assurance Maladie des Travailleurs Salaries, Sanofi, Institut National de la Sante et de la Recherche Medicale, Fondation de France. 1

Conseil Régional Bourgogne Franche-Comté 1

Conseil régional de Bourgogne 1

Conseil Régional de Bretagne; Institut de veille sanitaire; Ministère du Travail 1

Conseil Régional de Bretagne - Programme "appropriation sociale des sciences" 1

Conseil Régional de l'Île-de-France 1

Conseil Régional de l'Ile de France (CRIdF) Conseil Général du Val d'Oise (CG95) Agence de l'Eau Seine-Normandie (AESN) Syndicat Interdépartemental pour l'Assainissement de l'Agglomération Parisienne (SIAAP) 1

Conseil Regional d'Ille-et- Vilaine and the Fondation Langlois and Europe Council. 1

Conseil Régional du Centre 1

Conseil régional Île-de-France 1

Contrat de recherche avec PSDR ; région Rhone-Alpes ; programme Liproco 1

Contrat de recherche clinique 2006 CRC-06049 1

Contrat de recherche entre l'Andra et l'université de Caen (octobre 2006-Mai 2008) 1

Contrat de recherche externalisée n°46126024<br />Contrat UJF n°N598 1

CONTRAT DE RECHERCHE POST-DOCTORALE BIR REGION Rhône-Alpes 1

Contrat d'étude entre DEPE et Pluriagri 1

Contrat DIACT 1

Contrat financé par la Mission Recherche de la direction de la recherche, des études, de l'évaluation et des statistiques (DREES) et la Caisse nationale de solidarité pour l'autonomie (CNSA) 1

Contrat Pilotype, financement OSEO 1

Contrat Pluriagri localisé à la DEPE 1

Contrat post-doctoral IUED Genève 1

Contrat STAC/DGAC : convention cadre n 2011-IA-33 2

Convention ADEME n° 06 10 C 0094 1

Convention de recherche contractuelle UBO établie entre la Société "Espace Pur" (Le Guilvinec), le CETMEF (Compiègne) et le laboratoire GEOMER - LETG UMR 6554 CNRS (UBO/IUEM) en tant que maître d'ouvrage. Cette étude visait à réaliser une expertise du procédé "Stabiplage®" comme moyen technique de lutte contre l'érosion du littoral sur la plage des Sables Blancs des communes de Plobannalec-Lesconil et Loctudy (Finistère). Responsables scientifiques : Serge Suanez et Alain Hénaff. Participants GEOMER : Serge Suanez, Alain Hénaff et Jean-Marie Cariolet. Durée de l'étude : février 2006 - septembre 2006. Rapport final délivré en décembre 2006. Financement société Espace Pur. 1

Convention de recherche MEEDDAT, programme paysage et développement durable 1

Convention de recherche, recherche appliquée 1

CONVENTION DE SUBVENTION MEEDDM 10-MUTS-E&T-2-CVS-086 (2100 214 673) / AGEPEAU 1

Convention partenariale avec le Parc naturel régional des Pyrénées catalanes 1

Coopération Royaume du maroc-Etat français, dans le cadre du Fonds de Solidarité Prioriataire intitulé " Appui institutionnel à la mise en oeuvre d'une politique d'Aménagement du Territoire rénovée au Maroc" 1

Corps des IPEF 1

Cotton Incorporated 1

Covidien 1

C.P., C.N.F. S.H.H. and S.M.Z. received funding from the German Research Foundation (DFG) through the Clinical Research Unit(CRU)296 and the Collaborative Research Centre (CRC) 841 and from the Landesforschungsförderung Hamburg LFF-FV 45 Geschlechtsdimorphismus im Immunsystem. This work has been funded in part by the Pathogenesis and the Viral Latency Programs of the Heinrich Pette Institute, Leibniz Institute for Experimental Virology. This work was supported by the <GS3>German Research Foundation (CRU296: AR232/25-2, DI 2103/2–2, HE 4617/1–2, AL 1043/2-1</GN3>) to P.C.A., A.D., K.H. and M.A. and CRC 841 to T.R. 1

CPER/FEDER Alibiotech program (2016-2020); Algerian Ministry of High Education and Scientific Research 1

Cree First Nations 1

Cree people of northern Quebec 1

CRIF 4

Crossject 1

CRSH 1

CRU326, Deutsche Forschungsgemeinschaft 1

Czech Republic‐conceptual development of research organization (Institute for Clinical and Experimental Medicine‐IKEM, IN 0002300). 1

Danone Institute 1

Danone Research 1

Dan Werb is supported by a US National Institute on Drug Abuse AvenirAward (DP2-DA040256-01) and a Canadian Institutes of Health Research NewInvestigator Award. Support for this project also comes from NIDA grantsR37-DA019829, R01-DA031074, R01-DA011591, and U01-DA03888602 and viaMILDECA support for COSINUS (INSERM/MILDECA C14-26). 1

Data collection was funded by the UK MedicalResearch Council (G0902037), the British Heart Foundationand the US National Institute on Aging (R01AG013196).Salary support received by the investigators was obtained fromthe Medical Research Council (G0902037 for Eric Brunner andMika Kivimaki), the National Institute on Aging(R01AG013196 and R01AG034454 for S.S,A. S-M, G.H-J, M. K),a European Young Investigator Award from the EuropeanScience Foundation (A. S-M) and anEconomic and Social Research Council professorial fellowship(M.K). 1

DATAR, groupe de prospective n° 3 1

DDT du Cantal 1

Dechra; Jurox; biochemistry department of Vetagro-Sup 1

Departement a la Recherche Clinique et au Developpement (DRCD), Assistance Publique-Hopitaux de Paris 1

Département de Seine-et-Marne 3

Département de Seine-Saint-Denis 2

Département Environnement & Agronomie de l’INRAE (D.E. 2013, Pari Scientifique 2016-2018) 1

Département Soutien et Formation, Institut de Recherche pour le Développement, DSF, IRD 1

Department of Linguistics and Germanic, Slavic, Asian, and African Languages of Michigan State University 1

Department of Linguistics at the University of Maryland, College Park, at the sixth annual Michigan State Undergraduate Linguistics Conference (MSULC) in East Lansing 1

(DFG, no. FZT 118); National Science Foundation Award nos. EF-0905606, EF-0832858, and DBI- 1300426 1

DGALFranceAgriMer 3

DGS, DDASS 1

Diabetes UK 1

DIACT / DATAR DIR. Martin Vanier 2006-2008 1

DIETPLUS - ANR-17-CE21-0003 1

DIM Matériaux anciens et patrimoniaux 1

Direction de la recherche clinique de l'AP-HP (PHRC 2001), INSERM U 149 (Recherches Épidémiologiques en Santé Périnatale et Santé des Femmes), Collège National des Gynécologues et Obstétriciens Français, Société Française de Médecine Périnatale, Fonds National de la Recherche Scientifique (Belgique). 1

Direction de la Recherche et de l’Animation Scientifique et Technique (DRAST) 1

Direction de la recherche et de l'innovation (DRI) 1

Direction generale de l'offre de soin (DGOS) 1

Direction Régionale de la Recherche Clinique 1

DiverIMPACTS (Diversification through rotation, Intercropping, Multiple cropping, Promoted with Actors and value chains towards Sustainability) - European Union's Horizon 2020 research and innovation program 727482 1

DRAC - SRA Normandie 1

Dr Carel has received grant funding from Ipsen and Takeda 1

DRIEE 1

DRIEE-IF 2

Drugs for Neglected Diseases Initiative (DNDi) and Médecins Sans Frontières, Switzerland. 1

Each author was funded by their public institute of affiliation. The manuscript preparation was funded by a grant from the University of Versailles (DIM SEnT 2011). 1

EC 2007-3612/001-001 1

EC2CO : Initiative Structurante Ecosphère continentale et côtière 1

ECCO, ESMO, ESTRO 1

EC/FP7/605170/EU/Configurable and Adaptable Trucks and Trailers for Optimal Transport Efficiency/TRANSFORMERS 2

EC/FP7/605368/EU/ROlling resistance, Skid resistance, ANd Noise Emission measurement standards for road surfaces/ROSANNE 1

Ecole Nationale Supérieure d'Architecture de Nancy 1

-ECONOMIE DE LA SECURITE ROUTIERE 1

Ecophyto 1

ECOS-CONICYT 12CH02 "Análisis comparativo franco chileno de dos instrumentos de desarrollo territorial: PER (Francia) y Cluster (Chile)" 1

ECOS-Sud 1

ECOS-sud-CONICYT (C07H03) La forêt de la cordillère côtière continentale et insulaire dans le sud du Chili: Dynamiques contemporaines et modélisations prospectives. 6

EdF-DTG, DDEA 38 1

Edwards Lifesciences 1

Edwards Life-sciences, Nyon, Switzerland 1

EEEL; "Emerging Energies, Emerging landscapes: Revisioning the Past, Constructing the Future" exploratory workshop European Science Foundation, 2007 . R2DS Ile de France, 2007-23 " Les paysages de l'énergie: Enjeux et politiques publiques ? " 1

EFSA 1

EFSA-Q-2015-00390 4

EHESP ; Direction générale de la santé ; Institut de recherche en santé publique ; Région Nord-Pas de Calais 1

EJS is supported by Wellcome Trust and the KWTRP at the Centre for Geographical Medicine Research‐Kilifi (supported by core funding from the Wellcome Trust (#203077/Z/16/Z)), with support from the International AIDS Vaccine Initiative. JDT is supported by NIAID R21AI20549. SF is supported by NIHR BRC. SER was supported by National Institutes of Health [R01 AI114320], [F30 MH098731] and [T32 GM008719]. 1

Electricite De France; Office de l'Eau Reunion; Region Reunion; Parc National de La Reunion; European Union (European Social Fund) 1

ENERGIC-OD 1

ENVITERA 1

EPIMAD is organized under an agreement between the Institut National de la Santé et de la Recherche Médicale (INSERM) and the Institut de Veille Sanitaire (InVS), and also received financial support from the François Aupetit Association. This study was partially funded by the PHRC 2011. 1

Equipex Matrice www.matricememory.fr 1

ERC grant agreement No. 802512 1

ESPON Applied Research 1

ESR MB001-029 1

EST-2016/1/49, Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail 2

Etablissement Français du Sang (CS/2002/009); GIS-Institut des Maladies Rares (GIS MR0428). 1

Ethypharm 1

Etude collaborative sur le système alimentaire dans la région Afrique du Nord / Moyen -Orient et ses évolutions potentielles ( 75000033 ) 2

Etude EFESE-EA 1

Etude financée par le Ministère de l'Alimentation, de l'Agriculture et de la Pêche, sur le programme 215 sous-action 22 (n° étude : 18285). 1

EU [501986] 1

EU 5th PCRD MOTIF ((EVK2-CT-2002-00153); ESF EUROCLIMATE/DECVEG; ANR Blanc 2006 - PICC 1

EU-CONSENT network of excellence, a European Commission Framework 6 programme 1

EU consortium BIO-DrIM (www.biodrim.eu), a CENTAURE foundation grant and under the auspices of the IHU-Cesti project, the Supervisory Committee in charge of trial safety and the Scientiﬁc Committee. 1

EUCOPE and Celgene Corporation. 1

EU-FEDER Operative Programme of Territorial Cooperation Spain France Andorra, 2007-2012 (POCTEFA), Project OTRAC 1

EU FP7 (Marie Curie Initial Training Network BOLD: Biology of Liver and the Pancreatic Development and Disease) 1

EUNephrOmics 1

EuReGene [LSHG-CT-2004 005 085] 1

EURenOmics [305608] 1

EURIAS fellowship at the Paris Institute for Advanced Studies (France), the European Union's 7th Framework Program for research, and the French State by the "Agence Nationale de la Recherche (program: Investissements d'avenir, ANR-11-LABX-0027-01 Labex RFIEA+)" 1

European branch of the International Life Sciences Institute (ILSI Europe) 1

European Commission 4

European Commission, Directorate General For Research & Innovation Innovation for Growth (I4G) 1

European Commission Joint Research Centre017841GOCE-CT-2003-505572282910 1

European Commission: Public Health and Consumer Protection Directorate; Research Directorate-General; Ligue contre le Cancer; Institut Gustave Roussy; Mutuelle Generale de l'Education Nationale; Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Institut National du Cancer (France); German Cancer Aid; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society: Health Research Fund (FIS) of the Spanish Ministry of Health (RTICC) [DR06/0020]; Catalan Institute of Oncology of Spain; Cancer Research UK; Medical Research Council, UK; Stroke Association, UK; British Heart Foundation; Department of Health, UK; Food Standards Agency, UK; Wellcome Trust, UK; Hellenic Ministry of Health; Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer; Compagnia San Paolo, Italy; Dutch Ministry of Public Health, Welfare and Sports; Dutch Ministry of Health; Dutch Prevention Funds; LK Research Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF); Statistics Netherlands (The Netherlands); Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane, Sweden; Nordforsk - Centre of Excellence programme; Spanish Ministry of Science and Innovation [CD09/00133] 1

European Commission's Directorate-General for Environment (DG ENV) 1

European Commission under the Life Science Health Priority of the 6th Framework Program (MOSAR network contract LSHP-CT-2007-037941) 1

European Community 1

European Community (European Funds for Regional Development, FEDER) 33245 NEONAT 1

European Cooperation in Science and Technology Action TU1208 Civil Engineering Applications of Ground Penetrating Radar 1

European Interreg3A Alcotra Program (Rockslidetec Project) Conseil Général de l'Isère (Pôle Grenoblois Risques Naturels) 1

European INTERREG IV programme; France-Suisse 2013-07 1

European Medicines Agency (EMEA); Ceva Sante Animale, Libourne, France 1

European Seventh programme 226465 1

European Society Clinical Nutrition and Metabolism 1

European Society of Clinical Microbiology and Infectious Diseases 1

European Synchrotron Radiation Facility (ESRF), experiment number SC 4778 1

European Union [ERANet-LAC CAPRI-PC HID-0254] 1

European Union (EU) 643576 1

European UnionEuropean Union (EU) [764458] 1

European Union; French Agropolis Fondation (RTRA - Montpellier) [1001-001] 1

Européen 2

Européen (appel d'offres international) 6

Expertise collective INRA CNRS 1

EXTREMES EAR-0711515 1

EYE-RISK project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634479. 1

F2G 1

FACCE-JPI Income 1

FCE 1

FCS 2009-2012ANR 1

FCT-ANR/BIA-BIC/0010/2013 1

Federation Francaise de Cardiologie 1

Federation Francophone de Cancerologie Digestive (FFCD) 1

Fédération nationale des parcs naturels régionaux de France Etude d'Evaluation des parcs naturels régionaux 1

Feder/État/Région Guadeloupe 1

FEDER ; La Région Guadeloupe 1

FEDER, through COMPETE2020 - Programa Operacional Competitividade e InternacionalizacAo (POCI), Programa Operacional Regional (POR) de Lisboa national funds (OE), through FCT/MCTES PTDC/BIA-ANM/4622/2014POCI-01-0145-FEDER-016754CESAM through national funds (OE) via FCT/MCTES UIDB/50017/2020+UIDP/50017/2020Sapere-Aude advanced grant from the Independent Research Fund Denmark DFF-8021-00308BFCT/MCTES through Programa Investigador IF/00899/2014Portuguese Foundation for Science and TechnologyEuropean Commission 1

Ferring 1

FFJ/Banque de France Fellowship 1

FIBA/UICN/UBO/CNRS 1

Financement ADEME 1017C001 1

Financement Ademe - 3ème Prédit 1

Financement ADEME et Ile de France 1

Financement Canadian Institute for Health Research 1

Financement conjoint de l'Agence de l'Environnement et de la Maîtrise de l'Energie (ADEME) et de la Ville de Paris. 6

Financement de l'ANR dans le cadre du projet ANR-11-ALID-0006ILLIAD 2

Financement de l'opération assuré par le Conseil Général de l'Hérault par le biais de l'Association de Protection et de mise en valeur du Patrimoine géologique du grand Sud-Ouest (ASPROGEO). 1

Financement Européen 1

Financement Jeune Chercheur.e Sidaction/Fonds de dotation Pierre Bergé 1

Financement par l'ERC (2009-2014) 1

Financement partiel de la mission par campus France (Agence française pour la promotion de l'enseignement supérieur) 1

Financement PEVS (CNRS) 1

Financial support consisted of a grant from the Assistance-Publique Hôpitaux de Paris (CRC 07 011), a nonprofit, government-funded organization. 1

Financial support for this work was provided by a French national clinical research grant (PHRC 2010–05). 1

Finep Brazil 1

FL has received a research grant from Astellas Pharma and has received funding to attend meetings and conferences; CC has received funding to attend meetings and conferences from Astellas Pharma; PHD and KB has received funding to attend meetings and conferences and speaker fees from Astellas Pharma. 1

Fnancial support from the TMENA2 project (ANR-17-CE39-0009-01) and grant ANR-17-EUR-0020 granted by the French Agence Nationale de la Recherche 1

FNRS (Fonds de la recherche scientifique - Belgique) 1

FNRS (Fonds National de la Recherche Scientifique de Belgique-FRS-FNRS-http) 1

Fondation ARC pour la Recherche sur le Cancer [PAIR VADS 2011]; La Ligue contre le Cancer; Institut National Du Cancer 1

Fondation Centaure, which supports a French research network in transplantation. 1

Fondation coeurs et Arteres; Ministere de la Sante; Institut de Veille Sanitaire; Institut National de la Prevention et de l'Education pour la Sante; Fondation pour la Recherche Medicale; Institut de Recherche en Sante Publique; Institut National de la Sante et de la Recherche Medicale; Institut National de la Recherche Agronomique; Conservatoire National des Arts et Metiers; Universite Paris 13 1

Fondation de France 1

Fondation de France, Dreal de Bretagne 1

Fondation de France et pour la thèse cofinancement du Syndicat mixte de la Côte d'Opale 1

Fondation de France / Fondation D&N Carasso – Ecosystèmes, Agricultures et Alimentation 1

Fondation de France, Fondation pour la recherche Médicale, Région Languedoc-Roussillon, Association Retina France, Rhones Poulenc, Essilor, Specia, Horiba ABX Montpellier, Centre de Recherche et d'Information Nutritionnelle 1

Fondation de l'Avenir, Paris - France ET4-737 Dijon University Hospital 1

Fondation de Recherche pour la Biodiversité 1

Fondation des Ponts et Chaussées 1

Fondation MAIF 2

Fondation Plan Alzheimer 1

Fondation pour l'agriculture et la ruralité dans le monde (FARM, Paris) 1

Fondation pour la Recherche Médicale, and SIRIC-SOCRATE 2.0, French Society of Radiation Oncology. 1

Fondation pour la Recherche Médicale, Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Agence Française de Sécurité Sanitaire des Produits de Santé, Regions Aquitaine, Bourgogne et Languedoc-Roussillon , Fondation de France, Programme Ministère de la recherche-Inserm "Cohortes et collection de données biologiques 1

Fondation pour la recherche médicale, Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Agence Française de Sécurité Sanitaire des Produits de Santé, the Regional Governments of Aquitaine, Bourgogne and Languedoc-Roussillon and, the Fondation de France, the Ministry of Research-Inserm Programme "Cohorts and collection of biological material" 1

Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; MGEN; Institut de la Longevite; Conseils Regionaux of Aquitaine and Bourgogne; Fondation de France; Ministry of Research; INSERM contracts with CNAMTS [Caisse Nationale d'Assurance Maladie de Travailleurs Salaries (French National Health Insurance Agency for Wage Earners)]; Lilly Novartis Pharma; sanofi-aventis; INSERM (Reseaux en Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France; ALFEDIAM; ONIVINS; Ardix Medical; Bayer Diagnostics; Becton Dickinson; Cardionics; Merck Sante; NovoNordisk; Pierre Fabre; Roche; Topcon 1

Fondation pour la Recherche Medicale ; French National Research Agency (ANR) ; National Institute for Research in Public health (IRESP: TGIR cohorte sante program) ; French Ministry of Health (DGS) ; Ministry of Research, France ; INSERM Bone ; Joint Diseases National Research (PRO-A) ; Human Nutrition National Research Programs ; Paris Sud University ; Nestle ; French National Institute for Population Health Surveillance (InVS) ; Institut National de la Sante et de la Recherche Medicale (Inserm) ; European Union (EU) ; Diabetes National Research Program through French Association of Diabetic Patients (AFD) ; French National Research Agency (ANR) ; Mutuelle Generale de ('Education Nationale a complementary health insurance (MGEN) ; French national agency for food security ; French speaking association for the study of diabetes and metabolism (ALFEDIAM) ; Quebec Ministry of Health and Social Services of the Quebec Longitudinal Study of Child Development 19982002 1

Fondation pour la Recherche Médicale (FRM) 1

Fondation pour la Recherche Médicale (FRMING20140129210, SPF20150934219, FDT201805005509, and DEQ20180339193), and the Fondation du Rein (award and grant FdR 2018/FRM/G.L) 1

Fondation pour la Recherche Médicale, grant number DBS20131128445 1

Fondation Sécurité Routière n°2014/MP/02 1

Fond National pour l'Aménagement et le Développement durable du territoire (FNADT) 1

Fondo Nacional de Desarrollo Regional 1

Fonds Communautaire Européen (FCE), plan de relance économique (2009) 1

"Fonds Erasme pour la Recherche Medicale" (Belgium) 1

Fonds pour la formation à la Recherche dans l’Industrie et l’Agriculture (F.R.I.A.), Belgium . 1

FP6 1

FP-7-Health-Innovation 1

FranceAgriMer (GNBrett project) 7120164497 1

France au Mozambique, l’Institut Français en Afrique du Sud et L'Université Eduardo Mondlane 1

France-Australia Science Innovation Collaboration (FASIC) 1

France Stratégie 1

FRB - Fondation pour la Recherche en Biodiversite ; MOBILIS program 1

French Agency for Drugs (ANSM) 1

French association for cancer research, Fondation de France, French National Institute for Cancer Research, Inserm, AMU, MSD Avenir, FX Mora Foundation 1

French biodiversity agency (AFB) 1

French-Brazilian CAPES COFECUB project [720/11] 1

French Caisse Nationale d'Assurance Maladie 1

French Clinical Biology Society (Société Francaise de Biologie Clinique); Association for Liver Research (l'Association pour l'Etude du Foie) 1

French de National Agency for Research; Société Française de Biologie Clinique (SFBC); Association pour l'Étude du Foie (AFEF) References [1] Manning DS, Afdhal NH. Diagnosis and quantification of fibrosis. Gastroenterology 1

French Embassy in Ethiopia 1

French Health Ministry 1

French Health Ministry (PHRC grant) 1

French Institute of Horse and Equestrian (IFCE) 1

French Institute of Public Health Research/Institute of Public Health 1

French Institute of Public Health Research/Institute of Public Health; French Health Ministry; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institute of Cancer; National Solidarity Fund for Autonomy; National Research Agency through French EQUIPEX ANR-11-EQPX-0038; PREMUP Foundation 1

French Institute of Public Health Research/Institute of Public Health; French Health Ministry; National Institute of Health and Medical Research (Inserm); National Institute of Cancer; National Solidarity Fund for Autonomy (CNSA); National Research Agency through the French EQUIPEX program of investments for the future [ANR-11-EQPX-0038]; PREMUP Foundation 1

French Institute of Public Health Research/Institute of Public Health; French Health Ministry; National Institute of Health and Medical Research [INSERM]; National Institute of Cancer; National Solidarity Fund for Autonomy [CNSA]; National Research Agency through the French EQUIPEX program of Investments for the Future [ANR-11-EQPX-0038]; PREMUP Foundation; Societe Francaise de Medecine Perinatale (SFMP); Journees Francophones de Recherche en Neonatalogie (JFRN) 1

French Institute of Public Health Research/Institute of Public Health; French Health Ministry; NIH and Medical Research; National Institute of Cancer; National Solidarity Fund for Autonomy; National Research Agency [ANR-11-EQPX-0038, ANR-12-SV, ANR-12-BSV3-0025001/EPIFLORE]; PremUp Foundation; Nestec Research Center (Vers-chez-les-Blanc, Switzerland) 1

French “Institut National des Sciences de l’Univers” (INSU) satellite programe, SNO-DYNALIT 1

French “Investissements d’Avenir” program, project ISITE-BFC (contract ANR-15-IDEX-0003), Conseil Régional Bourgogne Franche-Comté, and FEDER (European Funding for Regional Economic Development), and French MESR 1

French League against Cancer (LNCC) 1

French ministries: Astuce et tic project, Sirrimed project: European FP7 1

French Ministries of Research and Higher Education and of Agriculture, Food and Forestry (internship grants) ; Cancéropôle Ile-de-France, Ile-de-France Region (PhD grant) ; US National Institute for Diabetes and Digestive and Kidney Diseases [R44DK103377] 1

French Ministry for ecology, DRI, Predit program,Operational group 2, Agreement GO2 13-MT-G02-1-CVS-007 1

French Ministry of Health 4

French Ministry of Health and funded by the Departement de la Recherche Clinique et du Developpement; Assistance Publique-Hopitaux de Paris (AOR09024) 1

French Ministry of Health and Research (PHRC N°2006/1902) 1

French Ministry of Health and the Institut National du Cancer as part of the Programme Hospitalier de Recherche Clinique. This work was also supported by the Association for Training, Education, and Research in Hematology, Immunology, and Transplantation. The Institut Hospitalo-Universitaire-Cesti project is also supported by Nantes Metropole and the Pays de la Loire Region. 1

French Ministry of Health CRC 11059 ; Departement de la Recherche Clinique et du Developpement de l'Assistance Publique-Hopitaux de Paris 1

French Ministry of Health (DGS); French Institute for Health Surveillance (INVS); National Institute for Prevention and Health Education (INPES); Foundation for Medical Research (FRM); National Institute for Health and Medical Research (INSERM); National Institute for Agricultural Research (INRA); National Conservatory of Arts and Crafts (CNAM); University of Paris 13 1

French Ministry of Health (DGS); French Public Health Agency; French National Institute for Health and Medical Research (INSERM); Medical Research Foundation (FRM); French National Institute for Agricultural Research (INRA); National Conservatory for Arts and Crafts (CNAM); National Institute for Prevention and Health Education (INPES); Paris 13 University; Ecole Doctorale Galilee, Paris 13 University, Sorbonne Paris Cite 1

French Ministry of Health (DGS); French Public Health Agency; French National Institute for Health and Medical Research (INSERM); Medical Research Foundation (FRM); French National Institute for Agricultural Research (INRA); National Conservatory for Arts and Crafts (CNAM); National Institute for Prevention and Health Education (INPES); Paris 13 University; Ecole Doctorale Galilee; Sorbonne Paris Cite 1

French Ministry of Health (DGS) ; French Public Health Agency ; Institut National de la Sante et de la Recherche Medicale (Inserm) ; Fondation pour la Recherche Medicale ; French National Institute for Agricultural Research (INRA) ; National Conservatory for Arts and Crafts (CNAM) ; Institut National de la Sante et de la Recherche Medicale (Inserm) ; Paris 13 University ; Ecole Doctorale Galilee, Paris 13 University, Sorbonne Paris Cite 1

French Ministry of Health (DGS); Institut de Veille Sanitaire (InVS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Recherche Agronomique (Inra); Conservatoire National des Arts et Metiers (CNAM); Institut National de Prevention et d'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM); Universite Paris 13 1

French Ministry of Health (DGS); Institut de Veille Sanitaire (InVS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Recherche Agronomique (Inra); Conservatoire National des Arts et M tiers (CNAM); Institut National de Prevention et d'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM); Fondation Coeur et Arteres (FCA); Paris 13 University 1

French Ministry of Health (DGS) ; National Institute for Prevention and Health Education (INPES) ; French Ministry of Research and Higher Education ; Canceropole Ile-de-France 1

French Ministry of Health (DGS) ; National Institute for Prevention and Health Education (INPES) ; French Ministry of Research and Higher Education (internship grant) ; Cancéropôle Ile-de-France, Ile-de-France Region (PhD grant) 1

French Ministry of Health, Edwards Lifesciences (Irvine, CA, USA), St. Jude Medical (Minneapolis, MN, USA), and Sorin Group (Saluggia, Italy) 1

French ministry of health PHRC [15-07]; Geneva University Hospitals 1

French Ministry of Health [PHRC AOM 09 195] 1

French Ministry of Health (PHRC National) 1

French Ministry of Health (PHRC R 2007- R-04) 1

French ministry of health (PREQHOS) 1

French Ministry of Health (Programme de recherche sur la performance du systeme des soins) PREPS-16-42Assistance Publique-Hopitaux de Paris 1

French Ministry of Health, Programme Hospitalier de Recherche Clinique 2009. 1

French Ministry of Health (Programme Hospitalier de Recherche Clinique Interrégional API/N/041) - Centre de Référence des Infections Ostéo-articulaires du Grand Ouest (CRIOGO) 1

French Ministry of Health (Programme Hospitalier de Recherche Clinique Interregionale) API/N/041 - Centre de Reference des Infections Osteo-articulaires du Grand Ouest (CRIOGO) 1

French Ministry of Health (Programme Hospitalier de Recherche Clinique Interregionale grant API/N/041) ; Centre de Reference des Infections Osteo-articulaires du Grand Ouest (CRIOGO) 1

French Ministry of Higher Education, Research and Innovation 1

French Ministry of Labor (DARES) [2200727156] 1

French Ministry of Research and Education 1

French Ministry of Research and Higher Education (internship grant) ; Cancéropôle Ile-de-France, Ile-de-France Region (PhD grant) 1

French Ministry of Sustainable Development 1

French National Agency for Research on AIDS and Viral Hepatitis (ANRS, Paris, France) 1

French National Agency for Research on AIDS and Viral Hepatitis (ANRS). Roche, Schering-Plough, GSK, BMS, and Merck-Serono. 1

French National Agency for Research on Aids and Viral Hepatitis(ANRS) with the participation of Glaxo-SmithKline, Roche and Schering-Plough. 1

French National Agency for Water and Aquatic Environments (ONEMA); wedish Agency for Marine and Water Management; SLU Environmental Monitoring and Assessment program Lakes and Watercourses 1

French National Association of research and technology (ANRT), through a CIFRE grant (Conventions Industrielles de Formation par la Recherche) research - an association and a company (NIDAPLAST) 1

French National Cancer Institute [2007-1-SPC-3] 1

French National Cancer Institute (InCA) (#2009‐139) 1

French National Cancer Institute (INCa) ; ARC Foundation for Research on Cancer (Fondation ARC) 1

French National Cancer Institute (INCa)-Canceropole Ile-de-France [2017-1-PL SHS-01-INSERM ADR 5-1]; European Commission (DG-SANCO); International Agency for Research on Cancer; Danish Cancer Society (Denmark); Ligue Contre le Cancer, (France); Institut Gustave Roussy, (France); Mutuelle Generale de l'Education Nationale, (France); Institut National de la Sante et de la Recherche Medicale (Inserm), (France); Deutsche Krebshilfe (Germany); Deutsches Krebsforschungszentrum (Germany); Federal Ministry of Education and Research (Germany); Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy; Dutch Ministry of Public Health, Welfare, and Sports (VWS) (the Netherlands); Netherlands Cancer Registry (NKR) (the Netherlands); LK Research Funds (the Netherlands); Dutch Prevention Funds (the Netherlands); Dutch ZON (Zorg Onderzoek Nederland) (the Netherlands); World Cancer Research Fund (WCRF) (the Netherlands); Statistics Netherlands (the Netherlands); Health Research Fund (FIS) [PI13/00061]; Regional Government of Andalucia (Spain); Regional Government of Asturias (Spain); Regional Government of Basque Country (Spain); Regional Government of Murcia (Spain) [6236]; Regional Government of Navarra, ISCIII RETIC (Spain) [RD06/0020]; Swedish Cancer Society (Sweden); Swedish Scientific Council (Sweden); County Council of Skane (Sweden); County Council of Vasterbotten (Sweden); Cancer Research UK [14136, C570/A16491, C8221/A19170]; Medical Research Council [1000143, MR/M012190/1]; National Research Council (Italy) 1

French National Cancer Institute (Institut National du Cancer, INCa) [2007-1-SPC-3] 1

French National Institute for Agronomic Research (INRA) 1

French National Institute for Health and Medical Research INSERM U1153 ; French National Institute of Agronomy Research INRA U1125 ; Paris 13 University 1

French National Institute of Health and Medical Research; programme de recherches H1N1 Aviesan; Institut de Microbiologie et des Maladies Infectieuses 1

French National Institutes for Health and Medical Research (Inserm) 1

French national Programme EC2CO-Biohefect "MACROFLUX" ; Region Ile de France 1

French National Research Agency [ANR-05-PNRA-010]; French Ministry of Health (DGS); Ecole Doctorale Galilee, University of Paris 13, Sorbonne Paris Cite 1

French National Research Agency [ANR-05-PNRA-010]; French Ministry of Health (DGS); Societe Francaise d'Hypertension Arterielle [R13024KK RAK13204KKA]; Ecole Doctorale Galilee, Paris 13 University, Sorbonne Paris Cite 1

French National Research Agency [ANR-05-PNRA-010]; French Ministry of Health; Mederic; Sodexo; Ipsen; Mutuelle generale de l'Education nationale (MGEN); Pierre Fabre; Ecole Doctorale Galilee, University of Paris 13, Sorbonne Paris Cite; Association nationale de la recherche et de la technologie [CIFRE 474/2010] 1

French National Research Agency [ANR-05-PNRA-010]; Societe Francaise d'Hypertension Arterielle [R13024KK RAK13204KKA]; French Ministry of Health; US National Institute for Diabetes, Digestive, and Kidney Diseases [R44DK103377]; Paris 13 University 1

French National Research Agency (ANR): ANR-15-CE36-0002-01. 1

French National Research Agency (ANR) as part of the "Investissements d'Avenir" program [ANR-11-LABX-0002-01, ANR-11-INBS-0001]; Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret 1

French National Research Agency (ANR) through the ACASSYA project [ANR-08-STRA-01] 1

French National Research Agency (ANR) through the ALMIRA project [ANR-12-TMED-0003] 1

French National Research Agency (ANR) through the project ACIMP 1

French National Research Agency (grant ANR-10-ALIA-001 ORALISENS). 1

French National Research Agency through the national 'Investissements d'avenir' program (LABEX RESSOURCES21) ANR-10-LABX-21 ; French National Research Agency ANR-14-CE04-0005 ; Australian Research Council DE160100429 ; Australian Government Research Training Program Scholarship ; UQ Centennial Scholarship at The University of Queensland, Australia 1

French Nutrition Society (SFN), French National Cancer Institute [DEPREV14-027]; PhD grants from the Canceropole Ile-de-France from the Paris region; Ministere de la Sante, Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et M'etiers (CNAM); Universite Paris 13 1

French Research Institute for Public Health (grant AAR201206); Cancéropôle Ile-de-France (public funding from the Paris region) 1

French Research Institute for Public Health (IRESP) [AAR201206] ; Cancéropôle Ile-de-France, Ile-de-France Region (PhD grant) 3

French Research Institute for Public Health (IRSEP) ; AAR201206 Canceropole Ile-de-France (Paris region) 1

French Society for Infectious Diseases (Société de Pathologie Infectieuse de Langue Française [SPILF]); the French Institute for Public Health Surveillance (Institut de Veille Sanitaire [InVS]) 1

French Society of Cardiology 1

French society of gastroenterology (FARE grant); Biocodex 1

French Society of Rheumatology 1

French teams were supported by the French National Agency for Research 1

FRESHER (“FoResight and Modelling for European Health policy and Regulation”) is an interdisciplinary research project funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643576 for a duration of 36 months (2015-2018). The European Commission provided support in the form of salaries for GG, SB, SG, AR, FR, DC, and BV. 1

FRHTA, DIM 1

FS/16/14/32023, Senior Clinical Research Fellowship 1

FUI 19 YELLOW 1

FUI RE-SIST 1

Fundacao de Amparo a Pesquisa do Distrito Federal (FAPDF) 193.000.862/2014 1

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/09612-3, 2012/23762-0, 2013/03246-0, 2013/23355-9, 2014/07742-5, 2014/05220-1, 2015/22820-5, 2016/01259-6] 1

Funding for the Lamivir study was provided by Laboratoire GlaxoSmithKline, France 1

Funding for this study was provided by Sanofi-Pasteur. The sponsors of the study were involved in study design and review of the manuscript; the sponsors had no role in the data collection/analysis and the decision to publish was made jointly by all authors. 1

. Funding for this study was provided by the European Union's seventh framework programme FP7/2007-2013 under grant agreement 223102, by additional funding from the European College of Neuropsychopharmacology and by the Investissements d'Avenir program managed by the ANR under reference ANR-11-IDEX-0004-02. 1

Funding from the Société Française d’Anesthésie Réanimation, la fondation des ‘‘Gueules Cassées’’. 1

Funding was obtained by the CHU of Martinique from the French Ministry of Research and Higher Education (PHRC 2019 29-01). 1

Funding was provided by the French Ministry of Health (Support for Costly Cancer Technical Evaluation – STIC – Gov-0478). 1

FUTUROL - 11000226/R3D 1

GDR EGRIN 1

GDR MAGIS 1

Gen-Probe, Incoporated 1

Genzyme SAS 1

George Washington University 70NANB13H158 1

German Federal Agency for Nature Conservation (BfN) [3518 84 0500] 1

German Federal Ministry of Education and Research (BMBF) through the German Aerospace Center (DLR), association "Vaincre La Mucoviscidose" 1

GESSOL 3 1

G.H.-J. is supported by a grant from the National Institute on Aging, NIH (R01AG034454,principal investigators: A.S-M. and M.K.) and from the NHS Leeds Flexibility & SustainabilityFund (principal investigator: Fullard). S.S is supported by a grant from the National Instituteon Aging, NIH (R01AG034454, principal investigator: A.S-M. and M.K.). A.S.-M. is supportedby a grant from the National Institute on Aging, NIH (R01AG013196; R01AG034454). M.S. issupported by the British Heart Foundation. M.K. is supported by the Medical ResearchCouncil, the National Institutes of Health (R01HL036310; R01AG034454), the Academy ofFinland, and by a professorial fellowship from the Economic and Social Research Council(ESRC). The Whitehall II study is also supported by a grant from the British MedicalResearch Council (K013351) and the British Heart Foundation. Tracing of stroke eventswas funded by a grant from the Stroke Association (principal investigator: E.J.B). 1

Gilead 2

Gilead Sciences 1

GIS Maladies Rares 1

GlaxoSmithKline 1

G Menvielle received a funding from the Fondation pour la Recherche Médicale for this analysis. The project was in part funded by the European Commission, through the Eurocadet project (from the commission of the European communities research directorate-general, grant No EUROCADET:SP23-CT-2005-006528). EPIC was supported by the European Commission: Public Health and Consumer Protection Directorate 1993-2004 and the Research Directorate-General 2005-2008. European Commission FP5 project (QLG1-CT-2001-01049). The EPIC study was funded by "Europe Against Cancer" Programme of the European Commission (SANCO); Ligue contre le Cancer (France); Société 3M (France); Mutuelle Générale de l'Education Nationale; Institut National de la Santé et de la Recherche Médicale; German Cancer Aid; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Red Temática de Investigación Cooperativa de Centros de Cáncer (C03/10); the participating regional governments and institutions of Murcia, Navarra, Asturias, Pais Vasco y Andalucia, Spain; Cancer Research UK; Medical Research Council, United Kingdom; Stroke Association, United Kingdom; British Heart Foundation; Department of Health, United Kingdom; Food Standards Agency, United Kingdom; The Wellcome Trust, United Kingdom; Greek Ministry of Health; Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer; Dutch Ministry of Public Health, Welfare and Sports; Dutch Ministry of Health; Dutch Prevention Funds; LK Research Funds; Dutch Zorg Onderzoek Nederland; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Vasterbotten and Skane, Sweden; Norwegian Cancer Society; and Foundation to Promote Research into Functional Vitamin B12 Deficiency, Norway. Some authors are partners of Environmental Cancer Risk, Nutrition and Individual Susceptibility, a network of excellence of the European Commission (6FP contract 513943). Antonio Agudo and Paolo Vineis were supported by ECNIS. 1

GOCE-CT-2003-505572, Sixth Framework Programme 1

GOSPEL project 1

Grant from the Assistance-Publique Hôpitaux de Paris (AOM 00-06). 1

Grant from the Programme Hospitalier de Recherche Clinique (PHRC, AOM05116/P051014), Ministry of Health. 1

Grant funds from the Fondation CNP, and the Fondation de France, France. 1

Grant Recherche translationnelle Pays de la Loire — Délégation Interrégionale à la Recherche Clinique Grand Ouest and the European Society of Organ Transplantation Junior Clinical Research Grant. 1

Grants: This study was supported, in part, by a grant from the 'Direction de la Recherche Clinique' of the Nantes University Hospital (CHU), Nantes, France. 1

Grant support was from the French Society of Rheumatology and from Roche Chugai Pharma for serum adipokines and insulin measurement. Concerning the ESPOIR cohort, an unrestricted grant from Merck Sharp and Dohme (MSD) was allocated for the first 5 years. Two additional grants from INSERM were obtained to support part of the biologic database. The French Society of Rheumatology, Abbott, Wyeth-Pfizer, and Roche also supported the ESPOIR cohort study. 1

Grenelle de l'environnement, programme de recherche MEDDM 'Concertation, décision, environnement' (CEVIPOF / Sciences Po) 1

Groupe d'Etude des Lymphomes de l'Adulte, Paris, France; Grant No. 09/INS/2-03 from Cancer Institute, Sydney, New South Wales, Australia 1

GSK 2

Guillaume Lamé is supported by the Health Foundation’s grant to the University of Cambridge for The Healthcare Improvement Studies (THIS) Institute. THIS Institute is supported by the Health Foundation - an independent charity committed to bringing about better health and health care for people in the UK.Guillaume Lamé is supported by the Health Foundation’s grant to the University of Cambridge for The Healthcare Improvement Studies (THIS) Institute. THIS Institute is supported by the Health Foundation - an independent charity committed to bringing about better health and health care for people in the UK. 1

Gustave Roussy 1

Heart Leaflet Technologies 1

Helmsley Charitable Trust Association Francois Aupetit MSD France laboratories 1

HG, WA, AH, SB, MJ, AM, MS, MGY, FA, NF, MIA, AS. 30 $ for each submitted online CRF for data collection. funder name: by Roche Diagnostic Middle East FZCO. https://www.rochemiddleeast.com/ 1

Hologic Inc. (Bedford, MA) offered the test kits for E6/E7 viral mRNA detection of 14 high risk HPV types (APTIMA assay). There was no other funding. 1

Horizon 2020 2

Horizon 2020 Framework Programme, H2020H2020 Euratom, EURATOM 755523 1

Hospices Civils de Lyon 1

Hospital clinical research program n° 2014-A00354-43 1

ICaTSEM. Ce travail a bénéficié d'une aide de l'Etat gérée par l'Agence Nationale de la Recherche au titre du programme " Investissements d'avenir " portant la référence ANR-10-LABX-93-01. This work was supported by the French National Research Agency, through the program Investissements d'Avenir, ANR-10--LABX-93-01. 1

ICES 1

ID RCB 2015-A00314-45, Assistance Publique Hôpitaux de Marseille 1

IFRA Nairobi 1

IFRECOR 1

IFREMER through the project DIALTOXE (Diversite algale, efflorescences toxiques, eutrophisation) 1

IFRIS 1

IFSTTAR-CEREMA 1

IHU CESTI, Labex IGO and ARMINA consortia. 1

IMMY 1

ImPACT Program of Council for Science, Technology and Innovation, Cabinet Office, Government of Japan 1

INCa 1

INCT/CNPq collaborative grant : 574008/2008-0 ; ERC : 669609 ; Ontario Ministry of Research and Innovation ; Government of Canada through Genome Canada ; Ontario Genomics Institute 1

INNPRONTA Project [IPT-20111008]; CICY [AGL2013-49083-C3-1-R; AGL2016-79113-R]; Instituto de Salud Carlos III, ISCIII (CIBEROBN) from Spanish Ministrerio de Economia y Competitividad (MEC) (AEI/FEDER, UE); Generalitat de Catalunya (GC) [2014 SGR 773]; Alfonso Martin Escudero Foundation [EA 1517] 1

INRA 1

INRA (AAP2010 Gestion durable des résistances-ParcelR); Agence Nationale de la Recherche (ANR-2010-STRA-001-01 VirAphid); Ministère de l’Agriculture, de l’Alimentation et de l’Environnement (CTPS 25-C-2011-09 and CASDAR 12-1278 Agath) 1

INRA and the Agreenskills+ fellowship program, which received funding from the EU’s Seventh Framework Program under grant agreement No. FP7-609398. 1

INRA ; Conseil régional de Midi-Pyrénées 1

INRA divisions of Nutrition, Chemical Food Safety and Consumer Behaviour, and Social Sciences, Agriculture and Food, Rural Development and Environment 1

INRA; INPT EI Purpan; French National Agency for Research; Programme "Assessing and reducing environmental risks from plant protection products (pesticides)"; French Ministry in charge of Ecology and Sustainable Development (project "ASPIB") 1

INRA ; Institute Pasteur de Lille 1

INRA meta programme "Sustainable management of crop health" Smach P102-11 1

INRA, Région Bourgogne 1

INRA; Région Midi-Pyrénées; FEDER; Union européenne; Toulouse AgriCampus 1

INSERM,CNAMTS,Lilly,Novartis Pharma and Sanofi-Aventis,by INSERM(Réseaux en Santé Publique,Interactions entre les determinants de la santé),by the Association Diabète Risque Vasculaire,the Fédération Française de Cardiologie,La Fondation de France, ALFEDIAM, ONIVINS,Ardix Medical,Bayer Diagnostics,Becton Dickinson,Cardionics, Merck Santé,Novo Nordisk,Pierre Fabre,Roche,Topcon 1

INSERM,CNAMTS,Lilly,sanofi-aventis,Novartis Pharma;by INSERM Réseaux en Santé Publique,INSERM Interactions entre les determinants de la santé,the Association Diabète Risque Vasculaire,the Fédération Française de Cardiologie,La Fondation de France,ALFEDIAM, ONIVINS,Ardix Medical,Bayer Diagnostics,Becton Dickinson,Cardionics,Merck Santé,Novo Nordisk,Pierre Fabre,Roche,Topcon. 1

INSERM, CNAMTS, the Diabetes and Vascular Risk Association, the French Cardiology Federation , the France Foundation, ALFEDIAM, ONIVINS, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Lilly, Merck Santé, Novartis Pharma, Novo Nordisk, Pierre Fabre, Sanofi-Aventis, Roche, Topcon 1

INSERM, FRM, ANR Progarm, CNRS, ARC 1

Inserm, Institut National de la Santé et de la Recherche Médicale 1

INSERM (Institut National de la Santé et de la Recherche Médicale) and the Cayenne General Hospital. 1

INSERM; the French National Research Agency; the French Agency for Food, Environmental and Occupational Health & Safety 1

Institut de la Mère et de L'enfant 1

Institut de la Mobilité Durable (Renault et ParisTech) Ecole des Ponts 1

Institut des Amériques, Université Nice Sophia Antipolis, LIRCES, URMIS, LAPCOS, CRHI 1

Institut de Veille Sanitaire 1

Institute Emilie du Châtelet (Ile-de-France Region); Agence de Biomedecine; Research Institute of Public Health (IReSP) 1

Institut Français de la Biodiversité, Fondation de France 1

Institut Interuniversitaire de Médecine du Travail de Paris Ile-de-France 1

Institutional funds. 1

Institut National de la Recherche Agronomique; Universite Pierre et Marie Curie 1

Institut National de la Sante et de la Recherche Medicale (INSERM) 1

"Institut National de la Sante et de la Recherche Medicale" (INSERM) "Conseil General de Bourgogne" (France) "Fonds Europeen de Developpement Regional" (FEDER) 1

Institut National Du Cancer 1

Institut National du Cancer (INCA) 1

Institut National du Cancer INCa ; Cancéropôle Ile-de-France (public funding from the Paris région) ; Ministère de la Santé ; Institut de Veille Sanitaire (InVS) ; INPES ; Région Ile-de-France (CORDDIM) ; Fondation pour la Recherche Médicale (FRM) ; Institut National de la Santé et de la Recherche Médicale (INSERM) ; Institut National de la Recherche Agronomique (INRA) ; Conservatoire National des Arts et Métiers (CNAM) ; Université Paris 13 1

Institut National du Cancer; La Ligue Contre le Cancer d'Auvergne; La Region Auvergne 1

Institut National Du Cancer, INCa: 2012-218 Institut National de la Santé et de la Recherche Médicale, Inserm Ligue Contre le Cancer: AOM09 202 Université Paris Descartes Institut National de la Santé et de la Recherche Médicale, Inserm 1

Institut OPUS - SU 1

Institut Pasteur, Inserm, Santé Publique France, Programme Hospitalier de Recherche Clinique, Swiss National Science Foundation. 1

INSU - Service National d'Observation (SNO) DYNALIT 1

Interco-SSH is a project funded by the European Union under the 7th Research Framework Programme. Grant agreement n°319974 1

INTERLOIRE 1

Interprofessional Office of Burgundy Wines E110CVPARI 1

InVS/Direction of Labor grant n°03-S-ST-A20-08, AFSSET (French Agency of health safety, environment and work) grant N° ES-2005-015 and EU Framework program for research, research, contract n° FOOD-CT-2004-506378, the GA2LEN project, Global Allergy and Asthma European Network 1

IRES 1

IRESP 1

IRSTEA 1

ISBlue - Interdisciplinary Graduate School for the Blue planet (2017) 1

J08-12, ESPARR - ADEME 2

J09-01, ARTEMIS - émissions - ADEME 1

J10-25, SVRAI - DSCR 2

J11-11, TRANS ENERGY - ANR 1

J11-24, BETTI - ADEME 1

JAJGvdB is supported by grant DKF14OKG07 from the Dutch Kidney Foundation (www.nierstichting.nl); TD was supported by CogIMon H2020 ICT-644727. (https://ec.europa.eu/programmes/horizon2020/en/). The MASTERPLAN Study was supported by grant number PV01 from the Dutch Kidney Foundation (www.nierstichting.nl) and grant 2003B261 from the Netherlands Heart Foundation (Nederlandse Hartstichting, (www.hartstichting.nl). In addition, unrestricted grants were provided by Amgen, Genzyme, Pfizer and Sanofi-Aventis for the MASTERPLAN study. The NephroTest cohort study was supported by the following grants: INSERM (www.inserm.fr) GIS-IReSP AO 8113LS TGIR (B.S.), French Ministry of Health AOM 09114 (M.Fr.), INSERM AO 8022LS (B.S.), Agence de la Biomédecine R0 8156LL (B.S.), AURA (M.Fr.) and Roche 2009-152-447G (M.Fr.). 1

Janssen 1

JEAI (Jeune Equipe Associee a l'IRD) 'SAPALOTE' (Long Term Savannah Park); ANR ECLIS French programme; ANR French programme ESCAPE-10-CEPL-005; European Community; ECCO-PNRH French National Hydrological Research Programme 1

JP was supported by a grant from ANRS. 1

JUST, Mission Recherche Justice, Ministère de la Justice 1

JV, NS, MK and PS are supported by the Academy of Finland (grants #117604, #124271, #124322 and #129262) and MK is additionally supported by the BUPA Specialist research grant; HW is supported by the Swedish Council for Working Life and Social Research (FAS, grants #2004-2021, #2007-1143); JEF is supported by the MRC (Grant number G8802774); AS-M is supported by a EUYRI award from the European Science Foundation. 1

"Know and Pol" PCRD project 1

Labex DynamiTe 1

LABEX Futurs Urbains 1

Labex ICST 1

LABEX IMU (ANR-10-LABX-0088/ ANR11-IDEX-0007) 1

Labex IRON 2

Labex ITEM- ANR-10-LABX-50-01 4

Labex Mer 1

LabEx Mer 1

Labex SMS 1

Laboratoire francais du Fractionnement et des Biotechnologies 1

LDBIO 1

Leeds University 1

Le projet Gouv.Innov a été mené dans le cadre du troisième programme PSDR (Pour et sur le développement régional) co-financé par l’INRA, le Cirad, et pour les projets en Languedoc-Roussillon, la Région Languedoc-Roussillon. Les auteurs remercient aussi les partenaires de terrain du projet, et tout particulièrement les animateurs et responsables du Pays Corbières-Minervois, de la communauté d’agglomération Hérault-Méditerranée et du groupe technique «Urbanisme et agriculture» de l’Hérault. 1

Les auteurs remercient le LABEX ASLAN (ANR-10-LABX-0081) de l'Université de Lyon pour son soutien financier dans le cadre du programme "Investissements d'Avenir" (ANR-11-IDEX-0007) de l'Etat Français géré par l'Agence Nationale de la Recherche (ANR). 1

Les recherches sur les signalements profanes de clusters ont été financées par l'ADEME (Agence pour le développement et la maîtrise de l'énergie) # 04 10 C 0041, le programme CNRS SBSS (Sciences biomédicales santé société) # 08/2005/DR03, et le ministère de la Recherche (ATC Environnement-Santé) # 04 5667. 1

L'étude E3N-EPIC est réalisée grâce à la collaboration de la Ligue nationale contre le cancer et de ses comités départementaux, du programme Europe contre le cancer de la Communauté européenne, de la société 3M, de la Mutuelle générale de l'Éducation nationale, de l'Institut Gustave-Roussy, de l'Institut national de la santé et de la recherche médicale et de plusieurs conseils généraux. 1

LIA BeBEST 1

Ligue Contre le Cancer 1

Liséa Biodiversité 1

L. P. has received funding from Gilead, Janssen, MSD, and Viiv Healthcare for travel/accommodations/meeting expenses during the past 36 months not related to the submitted work. I. P. M. has received funding from Gilead, BMS, and Abbvie for board membership; from Gilead, MSD, and BMS as payment for lectures, including service on speakers bureaus; and from bms for travel/accommodations/meeting expenses during the past 36 months not related to the submitted work. All other authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. 1

LSHG-CT-2004-511978 and LHSB-CT-2003-503005 1

MAAF CASDAR 1

MaaT Pharma 1

Maison des Sciences de l'Homme de Bretagne (MSHB) through the PELICAN project 1

Maîtrise du cycle de vie des ouvrages : MCV 1

Marie Curie International Research Staff Exchange Scheme Fellowship and Emergence Program (N° 11P03919 /11P03921) Basse-Normandie Région. 1

Maryland Language Science Center 1

Matinas 1

M-C Desseroit’s PhD is partly funded by Brest Métropôle Océane. F. Tixier is funded by the association “Sport and Collection”, CHRU Poitiers. This work has received a French government support granted to the CominLabs excellence laboratory and managed by the National Research Agency in the "Investing for the Future" program under reference ANR-10-LABX-07-01. With the support of the National Institute of Cancer (INCa project #C14020NS). The original trials from which the images used in this study were obtained were supported by the U.S. National Cancer Institute through grants U01-CA079778 and U01-CA080098 and by Merck & Co., Inc. 1

MedDay Pharma 1

MEDDE 1

MEDDM (Liteau 3), Région Bretagne, CNRS 1

Medical Research Council 1

Medicines Company 1

MED-INN LOCAL 1

Medpace 1

Medtronic 1

Medtronic, Inc. 1

Medtronic plc. 1

Melinta 1

Merck 1

Merck KGaA 1

Merck Lipha santeRegistered Trademark, Lyon, France 1

Merck Serono, National League against Cancer (Ain and Rhône committees), CONTICANET network. 1

Merck Serono S.A.S. (France), an aliate of Merck KGaA (Darmstadt, Germany), supported this trial through grants to AGEO, but had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The AGEO Group sponsored the trial and investigators were responsible for study design,data collection, data analysis, and data interpretation. 1

Merck, Sharp and Dohme-Chibret Laboratoires, EISAI laboratoire 1

Merck Sharp Dohme; GA2LEN project; Global Allergy and Asthma European Network; Conseil scientifique AGIR pour les maladies chroniques, National Hospital program of clinical research (PHRC-national) 1

Meso Scale Diagnostics 1

Métaprogramme EcoServ : Services Ecosystémiques (2014-2018) 1

MGEN (Mutuelle Generale de l'Education Nationale); Gustave Roussy Institute; French League against Cancer; European Union [LSHM-CT-2006-037197]; French Research Agency (ANR) [ANR-10-COHO-0006]; Idex Paris Saclay Nutriperso project 1

Miltenyi 1

Ministère de la culture 1

Ministère de la Culture 1

Ministère de la culture de la République de Croatie 1

Ministère de l'Agriculture et de l'Alimentation, Projet COMPETLAIT 1

Ministère de l'Agriculture et de l'Alimentation (projet Metha'Revenus, CEP 2018 AAP 01), PSDR4 (projet BIOCA) 1

Ministère de l'Alimentation, de l'Agriculture et de la Pêche 1

Ministere de la Recherche 1

Ministere de la Sante 1

Ministere de la sante a pharmaceutical grant from Pfizer France 1

Ministère de la Santé, Institut de Veille Sanitaire (InVS) ; Institut National de la Prévention et de l’Education pour la Santé (INPES) ; Région Ile-de-France (CORDDIM), Institut National de la Santé et de la Recherche Médicale (INSERM) ; Institut National de la Recherche Agronomique (INRA) ; Conservatoire National des Arts et Métiers (CNAM) ; French National Cancer Institute [INCa_8085] (Université Paris 13) ; PhD grants from the Canceropôle Ile de France/Région Ile de France (public funding) 1

Ministere de la Sante; Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Region Ile-de-France (CORDDIM); Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13; Canceropole Ile de France/Region Ile de France; French National Cancer Institute [INCa_8085] 1

Ministere de la Sante ; Institut de Veille Sanitaire (InVS) ; Institut National de la Prevention et de l'Education pour la Sante (INPES) ; Region Ile-de-France ; Institut National de la Sante et de la Recherche Medicale (Inserm) ; Institut National de la Recherche Agronomique (INRA) ; Conservatoire National des Arts et Metiers (CNAM) ; Universite Paris 13 1

Ministère de la Santé, Santé Publique France, Institut National de laSanté et de la Recherche Médicale (INSERM), Institut National de laRecherche Agronomique (INRA), Conservatoire National des Arts et Métiers(CNAM) and Sorbonne Paris Nord University 1

Ministere de la Sante, Sante Publique France ; Institut National de la Sante et de la Recherche Medicale (INSERM) ; Institut National de la Recherche Agronomique (INRA) ; Conservatoire National des Arts et Metiers (CNAM) ; Universite Paris 13 ; Fondation de France ; French National Cancer Institute INCa_8085 1

Ministère de l'Ecologie 1

Ministère de l'Ecologie, de l'Energie, du Dévelopement durable et de la Mer : Projet Risque Décision Territoire 2 (AcTerre) 1

Ministère de l'Écologie, de l'Énergie, du Développement durable et de la Mer (MEEDDM) 1

Ministère de l’écologie, de l’énergie, du développement durable et de la mer, programme Eaux et Territoires : Contrat AGEPEAU 1

Ministère de l'écologie, du développement durable et de l'énergie 1

Ministère de l’Écologie, du Développement Durable et de l’Énergie 1

Ministère de l'écologie, du développement durable et de l'énergie,Chaire Finance Durable et Investissement Responsable,Labex ECODEC (projet RESSOR et FORTERESSE, GENRE)CEPREMAP (projet GENRE) 1

Ministère de l'Ecologie et de l'Agriculture 1

Ministère de l’Education Nationale et de la Recherche [EA7361] ; Université Paris-Sud ; Université Paris Saclay ; ANR [ANR-10- LABX-33] 1

Ministère de l'enseignement supérieur et de la recherche scientifique et de la technologie TunisieBEI - Banque Européenne d'Investisssement 1

Ministère de l'Équipement, des Transports, du Logement, du Tourisme et de la Mer (METLTM) 1

Ministère de l'Équipement et du Logement et des Transports – Plan Urbanisme Construction Architecture (MELT-PUCA) 1

Ministère des affaires étrangères 1

Ministère des Affaires Etrangères français 1

Ministère des affaires sociales, de la santé et du droit des femmes, Ministère aux personnes handicapées et à la lutte contre l'exclusion 1

Ministère des Transports, de l’Équipement, du Tourisme et de la Mer (MTETM) 1

Ministère en charge de l'écologie 4

Ministères en charge de l’Environnement et de l'Agriculture et l’Ademe. 1

Ministerie van Volksgezondheid, Welzijn en Sport, VWS Deutsche Krebshilfe Cancer Research UK, CRUK: C8221/A19170, 14136 VetenskapsrÃ¥det, VR Ministerie van Volksgezondheid, Welzijn en Sport, VWS Ligue Contre le Cancer German Cancer Research Center, DKFZ Bundesministerium fÃ¼r Bildung und Forschung, BMBF Bundesministerium fÃ¼r Bildung und Frauen, BMBF Institut National de la SantÃ© et de la Recherche MÃ©dicale, Inserm KrÃ¦ftens BekÃ¦mpelse, DCS Instituto de Salud Carlos III, ISCIII: PI15/00639 German Cancer Research Center, DKFZ National Research Council, NRC 6236 Generalitat de Catalunya European Commission, EC European Regional Development Fund, FEDER Centre International de Recherche sur le Cancer, CIRC RD06/0020 Deutsche Krebshilfe German Cancer Research Center, DKFZ PI13/01162, PI13/00061 Cancerfonden World Cancer Research Fund, WCRF: ERC-2009-AdG 232997 NordForsk Associazione Italiana per la Ricerca sul Cancro, AIRC Medical Research Council, MRC: MR/M012190/1 European Regional Development Fund, FEDER 1

Ministerie van Volksgezondheid, Welzijn en Sport, VWS Deutsche Krebshilfe Cancer Research UK, CRUK: C8221/A19170, C570/A16491 VetenskapsrÃ¥det, VR Ministerie van Volksgezondheid, Welzijn en Sport, VWS Ligue Contre le Cancer Bundesministerium fÃ¼r Bildung und Forschung, BMBF Bundesministerium fÃ¼r Bildung und Forschung, BMBF Institut National de la Santé et de la Recherche Médicale, Inserm KrÃ¦ftens BekÃ¦mpelse, DCS CAN 2016/545 German Cancer Research Center, DKFZ National Research Council, NRC Cancer Research Foundation in Northern Sweden European Commission, EC Centre International de Recherche sur le Cancer, IARC RD06/0020 German Cancer Research Center, DKFZ Cancerfonden PI13/01162, PI13/00061 World Cancer Research Fund, WCRF: ERC-2009-AdG 232997 NordForsk Associazione Italiana per la Ricerca sul Cancro, AIRC Medical Research Council, MRC: MR/M012190/1 1

Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Madrid, Spain - Spanish Network for Research in Infectious Diseases (REIPI RD06/0008) 1

Ministry of Education, Universities and Research (MIUR) 1

Ministry of Health. 1

Mission de recherche Droit et Jusitce 1

Mission de recherche Droit et Justice 1

MITI CNRS 1

MJYP received fellowships from "le Ministère de l'Education Nationale, de la Recherche et de la Technologie" and from SIDACTION. JFD received a fellowship from the French Agency for AIDS Research (ANRS). PSR was supported by a fellowship from the «Fundação para a Ciência e Tecnologia». IP is supported by NIH grants ROI AI064066 (IP) and P51RR000164. This study was supported by grants from the ANRS and The Institut Pasteur. 1

Modelling European Agriculture with Climate Change for Food Security (MACSUR) 1

Molecular analysis of LCH samples was supported by a grant (#11413) from the Conquer Cancer Foundation ASCO Young Investigator Award, supported by the Strike 3 Foundation. This study received grants from the Société Française de lutte contre les Cancers de l’Enfant et de l’Adolescent; Fédération Enfants et Santé; Association Recherche et Maladie Hématologiques de l’Enfant; Association Les 111 des Arts de Paris; Association la Petite Maison dans la Prairie. This project received constant support from the Association Histiocytose France. The French LCH registry was supported by a grant from InVS and INSERM for the rare disease registry, a grant from Roche and from the Gardrat Family. This study was based on research from the Centre de Reference des Histiocytoses (www.histiocytose.org). 1

MSD 3

MSD, AstraZeneca and Lundbeck 1

MSD France 1

MSHST 1

Mutuelle Générale de l’Education Nationale, Institut National de laSanté et de la recherché Médicale, Institut Gustave Roussy, 3M Company 1

Mutuelle Générale de l’Education Nationale (MGEN) 1

Mutuelle Générale de l’Education Nationale (MGEN); the European Community; the French League against Cancer (LNCC); Gustave Roussy; and the French National Institutes for Health and Medical Research (Inserm). French National Cancer Institute (InCA) (#2009-139). 1

NA, Donald D. Hammill Foundation. 1

Nantes Metropole and the Pays de la Loire Region. 1

National Agency for Drug Safety and Health Products (ANSM) [AAP-2014-030]; Assistance Publique-Hopitaux de Paris, Direction a la recherche Clinique et a l'Innovation (DRCI) 1

National Agency for Research on Acquired Immune Deficiency Syndrome and Viral Hepatitis, Agence Nationale de Recherche sur le Sida 1

National Authority for Health (HAS) 1

National Cancer Institute 1

National Council for Scientific and Technological Development (CNPq)447529/2014-5310359/2014-7 1

National Health and Medical Research Council [124317, 396414, 209057]; National Heart Foundation; Centre for Clinical Research Excellence in Clinical Science in Diabetes 1

National hors Recherche 16

National hors Recherche (appel d'offres national ou régional) 3

National hors Recherche Collectivités territoriales (partenariat avec la sphère publique (sans AO)) 2

National hors Recherche Européen 1

National hors Recherche National Recherche Collectivités territoriales Privé (partenariat avec la sphère publique (sans AO)) 1

National hors Recherche (partenariat avec la sphère publique (sans AO)) 34

National hors Recherche (partenariat avec la sphère socio-économique) 1

National Hospital Clinical Research Program from the French Ministry of Health 2011-A01288-33, French-speaking society of clinical nutrition and metabolism (SFNEP), Nutricia Clinical Nutrition SAS 1

National Institute for Public Health Surveillance (InVS); the French Ministry of Labor 1

National Institute of Applied Sciences-Lyon Institut National de la Sante et de la Recherche Medicale (Inserm) 1

National Institute of Cancer 1

National Institute of Health and Medical Research 1

National Institute of Health and Medical Research [INSERM U557]; French National Institute for Agricultural Research [INRA U1125]; Paris 13 University; CORDDIM 1

National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale - INSERM); the National Research Agency (ANR); the French Agency for Environmental and Occupational Health Safety (AFSSET); the National Endocrine Disruptor Research Program of the French Ministry of Environment; the General Health directorate (DGS); the French Institute for Public Health Surveillance. 1

National Institute of Standards and Technology's Foreign Guest Researcher Program 1

National Institute on Alcohol Abuse and Alcoholism (2U10 AA 13566); National Institute on Aging (K23 G00826); Robert Wood Johnson Generalist Faculty Scholar Award; an Inter- Agency Agreement between National Institute on Aging, National Institute of Mental Health, and the Veterans Health Administration; the VHA Office of Research and Development; and, VHA Public Health Strategic Health Care Group. 1

National Institutes of Health 1

National Institutes of Health [DK58845, P30 DK46200]; National Alliance for Research on Schizophrenia Depression [5048070-01]; National Heart, Lung, and Blood Institute [K99HL098459]; Fonds de recherche en sante du Quebec (FRSQ); NIH from National Heart, Lung, and Blood Institute [HL036310-20A2]; NIH from National Institute of Aging [AG034454, K08AG029813]; BUPA Foundation, UK; NIH from National Institute of Mental Health [R01MH091448] 1

National Institutes of Health (grants R01-AI073127 and U10-AA013566); the Medical Research Council (grant G0700820). 1

National Institutes of Health UM1 CA176726. 1

National Recherche 9

National Recherche (appel d'offres international) 1

National Recherche (appel d'offres national ou régional) 2

National Recherche Collectivités territoriales 1

National Recherche (partenariat avec la sphère publique (sans AO)) 16

National Research Agency through the French Equipex Program of Investments in the Future [ANR-11-EQPX-0038] 1

National ScienceCentre, Poland 1

National Science Foundation grant no. EPS-0904155, to Maine EPSCoR at the University of Maine 1

National Science FoundationNational Science Foundation (NSF) 1

National Solidarity Fund for Autonomy 1

Natural Environment Research Council (NERC); Royal Society for the Protection of Birds (RSPB); Arcadia; Natural Environment Research Council NE/N014472/1 1

NA, William Stamps Farish Fund 1

NCT01651585, NCT01923636 1

NEEDS 1

NERC-ESRC 1

NERC Natural Environment Research Council; Royal Society for the Protection of Birds; National Research Foundation - South Africa; NERC Natural Environment Research Council NE/N014472/1; Basic Science Special Project of MOST 2013FY110300 CAS NOXDA19050204; Arcadia; BiodivERsA 1

NewGov (6ème PCRD) "Choix et combinaison des instruments" (2005-2008) 1

NewGov; Centre d'études européennes de Sciences Po Paris 1

New Zealand’s Bragato Research Institute, New Zealand Winegrowers, and the New Zealand Ministry of Business, Innovation, and Employment (MBIE). 1

Niskamoon Corporation 1

NIST 70NANB13H158 1

No funding was required for the preparation of this protocol. The development of the DemReg register and clinical examinations are funded by the WLMHT Research and Development fund as well as North Thames Dementia and Neurodegenerative Diseases Research Network (DemReg). Supplementary funding is currently being sought for biological testing and imaging from public funds. 1

None. 1

Northern Contaminants Program (Indigenous Affairs and Northern Development Canada) 1

Northern Pulse Growers 1

Norwegian Ministry of Health; Ministry of Education and Research, the National Institute of Health, NIH/NIEHS [NO1-ES-75558]; NIH/NINDS [1 UO1 NS 047537-01, 2 UO1 NS047537-06A1]; Norwegian Research Council/FUGE [151918/S10]; National Institutes of Health (USA), National Institute on Aging [R01020048] 1

No source of financial support for the research. 1

Novartis 4

Novartis Animal Health 2

Novartis, Bayer, Allergan, Roche, EVICR, Thea, Horus, Novartis Pharma AG. 1

Novartis, France 1

Novartis Laboratories 1

NovoNordisk Grant 1

NP received PhD funding from the Sites de Recherche Intégré sur le Cancer (SIRIC) « CARPEM ». EZ received salary through the INSERM Physicancer program (no. PC201423). This work was supported by the Agence Nationale de la Recherche (ANR Nanobiotechnologies; no. ANR-10-NANO-0002-09), the canceropole funding (no. 2011-1-LABEL-UP5-2), the Ligue contre le cancer (Program "Equipe labelisée LIGUE"; no. EL2016.LNCC/VaT) and the French National Cancer Institute (INCA). 1

NSF IGERT Grant [0801465] 1

NSF Linguistics Doctoral Dissertation Research Improvement grant [BCS 1650791] 1

Nunavik Regional Board of Health and Social Services 1

NutriNet-Santé study was supported by the following French public institutions: Ministère de la Santé, Santé Publique France, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Recherche Agronomique (INRA), Conservatoire National des Arts et Métiers (CNAM) and Université Paris-XIII Nord. The Milieu Intérieur Consortium was supported by French Government’s Investissement d’Avenir Program, Laboratoire d’Excellence “Milieu Intérieur” Grant ANR-10-LABX-69-01. Valentin Partula was funded by Ph.D. a grant from the Labex Milieu Interieur, and is provided financial support from École doctorale 474 Frontières de l’Innovation en Recherche et Education – Programme Bettencourt. 1

OCDE 1

Office National de l’Eau et des Milieux Aquatiques 1

OHM Littoral méditerranéen 1

OHM Littoral méditerranéen - CNRS 1

One funding/research grant was received to support this study from University Paris-Diderot (Action Structurante Dental faculty Garancière). 1

Onema 2

Onema, Agence de l'Eau Seine-Normandie, Ministère français de l'Environnement 1

ONEMA (APR Pour et Sur le Plan ECOPHYTO, PSPE) 1

Onilait 1

Open Big Data project of the 2013 Interdisciplinary Programme on Communication Sciences of the French National Centre for Scientific ResearchLAPSI 2.0, the European Thematic Network on Legal Aspects of Public Sector Information 1

OPUR 1

OPUR, PIREN 1

OPUR research program 1

Orkyn’ 1

ORSI OBAMO 1

ORTHONGEL, IRD, Direction des Pêches Maritimes et de l'Aquaculture 1

OSCAR FP7-KBBE 289277/ CIMAS trial from the LIFEll ENV/IT/000302 IPNOA/ SOLIBAM FP7-KBBE 245058/FP6 Grain Legumes Integrated Project/ Food-CT-2004-506223 1

OSU-IUEM 1

OSU-IUEMLabexMer 1

Oticon Medical (Vallauris, France) 1

Our study has been funded by Instituto de Salud Carlos III through the project PI15/00639 (Co-funded by European Regional Development Fund [ERDF], a way to build Europe). We thank CERCA Programme/Generalitat de Catalunya for institutional support. Regional Government of Asturias, German Cancer Aid, German Cancer Research Center (DKFZ), Federal Ministry of Education and Research (BMBF). The coordination of EPIC is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle G?n?rale de l'Education Nationale, Institut National de la Sant? et de la Recherche M?dicale (INSERM, France); German Cancer Aid, German Cancer Research Center (DKFZ), Federal Ministry of Education and Research (BMBF), Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); ERC-2009-AdG 232997 and Nordforsk, Nordic Centre of Excellence programme on Food, Nutrition and Health (Norway); Health Research Fund (FIS), PI13/00061 to Granada, PI13/01162 to EPIC-Murcia), Regional Governments of Andaluc?a, Asturias, Basque Country, Murcia (no. 6236) and Navarra, ISCIII RETIC (RD06/0020; Spain); Swedish Cancer Society, Swedish Research Council and County Councils of Sk?ne and V?sterbotten (Sweden); Cancer Research UK (14136 to EPICNorfolk; C8221/A19170 to EPIC-Oxford), Medical Research Council (1000143 to EPICNorfolk, MR/M012190/1 to EPIC-Oxford, United Kingdom). 1

Parc Naturel Régional du Haut-Languedoc 1

Par la candidate 1

(partenariat avec la sphère publique (sans AO)) 4

Part of this study was supported by the ‘CPER/Region Guadeloupe’, grant nr. J-2-1-J210002, by the PHRC-API 2012, by APL 2010-Recherche Clinique CHU Pointe-a-Pitre, and by the ‘Conseil Regional de la Guadeloupe’, fellow-ship to R. H., who also received supports from the association ‘Guadeloupe - Espoir - Drepanocytose’, Club Soroptimist de Pointe-a-Pitre, Semsamar Guadeloupe and Fondation Semsamar Solidarites Saint-Martin 1

Pathoquest 1

Patrick Brou de Lauriere Fondation ; Celgene company ; Groupement Interregional de Recherche Clinique et d'Innovation Sud-Ouest OutreMer (GIRCI-SOOM) 1

Pays A3V (Conseil de Développement), financement de la Région Provence-Alpes-Côte-d'Azur 1

Pays de la Loire region in France 1

PCR-SRA Centre "Géoarchéologie de la Loire moyenne et de ses marges", CNRS « Interactions Sociétés-Milieux dans le bassin versant de la Loire", Zone Atelier CNRS "bassin versant de la Loire", PNRZH Loire, projet «Dynamique Fluviale» BRGM 1

PEPTIDE is financially supported by the Regional Hospital Clinical Research Programme. 1

Pfizer 5

Pfizer Ltd. France 1

PHRC 2

PHRC-12-009-0243, Direction de l’hospitalisation et de l’offre de Soins 1

PHRC 2006 1

PHRC Hospital-led Clinical Research Program: DRRC: AOM07014-P070127 1

PHRC National - Cerebral Palsy Foundation - Fondation Motrice/APETREIMC- INSERM - Dystonia national Network - Medtronic 1

PHRC National PROOF, 1998;PHRC National SYNAPSE, 2002; PHRC Regional Telamons, 2003 1

PIREN-Seine 2

PIREN-Seine program 1

PIREN-Seine programs 1

PIR Ville et Environnement 2008 (CNRS-PUCA) 1

PNR EST 1

PREDIT 1

PREDIT - DRI 1

PRES Toulouse University ; Midi-Pyrenees 1

PRIR "Magie" (Mobilisation des acteurs et gestion intégrée des espaces), financé par la Région Bretagne 1

PROMEP-SEP (México) 1

PRSE 2015 1

PSDR3 1

PSDR 3 Auvergne 1

PUCA : Programme Exploratoire de Recherche Prospective en Europe, Ministère de l'Equipement, des transports, de l'aménagement du territoire et de la mer. 2004-2006 1

PUCA, Programme Exploratoire de Recherche Prospective en Europe, Ministère de l'Equipement, des transports, de l'aménagement du territoire et de la mer. 2004-2006 1